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Tendinopathy is degenerative disorder of tendon characterized with longstanding 
tendon pain. In some cases, tendon with tendinopathic changes may coexist with 
calcium deposition, which is known as calcific tendinopathy. The origin of pain and 
pathogenesis of tendinopathy remain unclear. Sprouting of substance P (SP)-, 
calcitonin-gene related peptide- (CGRP) or their receptors-positive nerve fibers in 
clinical samples of chronic tendinopathy has been reported. While there are animal 
models for the study of tendinopathy, there is no such model for the study of calcific 
tendinopathy within chronic tendon pain. The follow-up time of the animal models 
was usually short. A method for the assessment of activity-related pain of 
tendinopathy in animals is also lacking. 
This study aimed to establish a patellar tendinopathy rat model using intratendinous 
collagenase injection and a gait analysis method for the assessment of activity-related 
pain in the same model. The pathogenesis of tendinopathy with specific emphasis on 
the identification of chondrocyte phenotypes was examined. The spatio-temporal 
changes of SP, neurokinin-1 receptor (NK-1R) and CGRP were studied. The 
correlations between expression of SP and different gait parameters were also 
investigated. 
After collagenase injection, increased cellularity, vascularity, extracellular matrix 
degeneration, with no infiltration of inflammatory cells were observed. While 
transient healing was observed at week 8, tendon failed to heal till week 32. Ectopic 
chondrogenesis, as confirmed by characteristic lacuna structure, sox-9 and collagen 
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ABSTRACT 
type II collagen expression was observed in the injured tendon. Calcific deposition, 
as demonstrated by von Kossa staining, was consistently observed in the injured 
tendon starting from week 12. This has not been reported in the previous animal 
models. That the calcific deposits were bone was further confirmed by the presence 
of pore-like structures in viva-CT images，polarization microscopy and presence of 
marrow-like cells inside the calcific deposits. Chondrocyte-like cells were mainly 
localized around the calcified nodules and they were both observed up to week 32 
post-collagenase injection. There was expression of type X collagen in 
chondrocyte-like cells surrounding the calcific deposits，suggesting that the 
calcification of the injured tendon was mediated by endochondral ossification. As 
sox-9 and type II collagen in tendon cells preceded their expression in 
chondrocyte-like cells, erroneous cell differentiation might occur and contribute to 
the pathogenesis of tendinopathy with calcific deposits. 
Hip forward velocity, stride length, and swing duration were significantly decreased 
while double stance duration was significantly increased after collagenase injection 
in our study. In addition，double stance duration was found to be highly correlated 
with SP expression in the injured tendon. 
The expression of SP and CGRP were increased in tendon cells，chondrocyte-like 
cells and cells embedded within calcific deposits and followed the failed healing 
status of the degenerative injury，indicating their non-neuronal sources of production 
and potential roles in the pathogenesis of chronic painful tendinopathy. NI-1R was 
expressed in cells around the vascular structure, suggesting roles in angiogenesis and 
vasoregulation. The gait parameters were also found to be associated with the 
expression of SP. 
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ABSTRACT 
In summary，we have developed a rat patellar calcific tendinopathy model and a gait 
analysis method for the assessment its painful response. SP and CGRP, NK-1R might 
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1.1 BASIC STRUCTURE AND BIOCHEMISTRY OF TENDON 
Tendons are the structures inserted between bone and muscle, which play an 
important role in force transmission from muscle to bone. A healthy tendon is 
composed of collagen fiber bundles and tendon cells, and they are closely packed in 
parallel alignment. A tendon is covered by a tendon sheath which gives it a glisten 
white appearance. Collagen fibers are arranged in the form of repeated units of 
collagen microfibrils. The repeated units of collage fibers is known as collagen fiber 
bundle (Rowe 1985). Beside collagen, proteoglycans, glycosaminoglycans (GAGs), 
and glycoprotein are the major ground substances of the extracellular matrix (ECM) 
in a healthy tendon (Kannus 2000; Sharma and Maffulli 2006). 
Around 55 to 70% wet weight of the tendon is water, while the rest is ground 
substances and tenocytes (Tipton, Matthes et al. 1975; Jozsa, Lehto et al. 1989; 
O'Brien 1997). Collagen is the major organic component of the tendon, with 
collagen type I being the dominant collagen type and it makes up around 60% of dry 
weight of tendon. Type III collagen makes up 10% of the dry weight. It plays an 
important role during tendon healing (Murphy, Loitz et al. 1994). There are also 
reports that small quantities of collagen type II，IV，V，and VI are present within the 
tendon (Kastelic, Galeski et al. 1978). 
There are two types of cell in a healthy tendon; tenocytes and tenoblasts. Tenocytes 
are spindle-shaped and are the major cell type in intact tendon. Tenocytes are 
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embedded within the collagen fiber bundles (Jozsa, Balint et al. 1979; Ippolito, 
Natali et al. 1980). Tenoblasts are round-shaped and are the active proliferating cells 
during repair. Cells other than tenocytes and tenoblasts such as inflammatory cells 
are rarely found within the healthy tendon. 
Tendon cells receive nutrients and oxygen through the arterioles. The arterioles are 
associated with the fat pad and on the tendon sheath. Both blood vessels and nerve 
fibers are rarely observed within a healthy tendon (Naito and Ogata 1983; Carr and 
Norris 1989). 
1.2 TERMINOLOGY 
Tendon disorder is a major musculoskeletal disease in occupational and recreational 
aspects (Renstrom 1991; Wilson and Best 2005). There are different clinical 
diagnosis and histopathological observations in different types of tendon disorder. 
Common tendon disorders include tendinitis, tendinosis, and tendinopathy. People 
often confuse tendinitis and tendinosis for chronic painful tendon disorder. 
In tendinitis, inflammatory cells were demonstrated in the tendon tissue. The suffix 
‘-itis，describes the inflammation status of the tendon, and that inflammation leads to 
the painful response of the tendon (Torstensen, Meen et al. 1994). The suffix '-osis' 
of tendinosis implies that the tendon is in a degenerative state, with matrix 
degeneration described as mucoid, myxoid, hyaline, fatty, or fibrinoid (Jarvinen, 
Jozsa et al. 1997); (Movin, Gad et al. 1997); (Movin, Kristoffersen-Wiberg et al. 
1998). As patients with chronic tendon pain have degenerative changes in the tendon 
CHAPTER 1 INTRODUCTION 
and there is no infiltration of inflammatory cell, the term "tendinosis" is suggested. 
Both tendinitis and tendinosis describe the histopathological changes only, without 
describing the clinical symptoms and diagnosis of the tendon. Clinicians and 
physicians thus prefer describing tendon disorders with clinical symptoms including 
longstanding tendon pain and swelling as well as histopathological changes with the 
term "tendinopathy" (Cook, Khan et al. 2002; Paavola, Kannus et al. 2002; Warden 
and Brukner 2003). 
In some cases, calcium deposition is observed in tendinopathy, and it is known as 
calcific tendinopathy (Hurt and Baker 2003). The occurrence of calcific 
tendinopathy have been reported in the patellar tendon (Lagier and Gerster 1991; 
Fenwick, Harrall et al. 2002)，mid-portion of the Achilles tendon (Fenwick, Harrall 
et al. 2002), rotator cuff and supraspinatus tendon (Faure and Daculsi 1983; 
Matsumoto，Ito et al. 2005). Tendinopathy and calcific tendinopathy are both 
challenging musculoskeletal conditions and there is no cure at present. 
1.3 EPIDEMIOLOGY OF TENDINOPATHY 
The prevalence of tendinopathy at different locations correlates with the degree of 
repetitive loading that leads to the overuse of tendon. However, calcific deposits 
could be coexisted with the tendinopathy at different locations of the body parts. 
Patellar tendon, Achilles tendon, and rotator cuff are thus tendons with high 
incidence rate of tendinopathy (Maffulli, Wong et al. 2003; Jarvinen, Kannus et al. 
2005; Scott and Ashe 2006; Wainstein and Nailor 2006). 
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Patellar tendinopathy is commonly diagnosed in sport activities with jumping 
motion such as soccer and volleyball (Martens, Wouters et al. 1982). Patellar 
tendinopathy has similar incidence rate in adolescents and adults (Cook, Khan et al. 
2000). Achilles tendinopathy is common in sport activities such as football, handball, 
running and tennis, as well as badminton (Winge, Jorgensen et al. 1989). This is 
often observed in male recreational runner who is at 35 to 45 year of age (Alfredson 
and Lorentzon 2000). Rotator cuff tendinopathy is common in sports with throwing 
motion, like baseball and handball (Arroyo, Hershon et al. 1997). The mean 
incidence age of rotator cuff tendinopathy is around 55, it has been reported that 
calcium deposition was commonly observed in rotator cuff tendinopathy (Jozsa and 
Kannus 1997). Lateral elbow tendinopathy is particularly common in tennis players, 
with peak incidence at the age of 40 to 50, and it is more common in male than that 
in female (Allander 1974; Verhaar 1994). 
1.4 CLINICAL SYMPTOMS AND DIAGNOSIS 
Patients with tendinopathy are usually presented with longstanding pain, swelling, 
tenderness, as well as stiffiiess at the affected region. Magnetic resonance imaging 
(MRI), X-ray, and ultrasonography (US) are frequently used for the diagnosis of 
tendinopathy. Features such as swelling, irregular shape of tendon sheath and 
disorganized ECM can be observed in the pathological tendons as hypoechogenic 
regions with MRI and ultrasonography (Kjellin, Ho et al. 1991; Khan, Bonar et al. 
1996). While the calcific deposits in calcific tendinopathy can be shown as 
hyperechogenic regions with MRI and ultrasonography, the most reliable method for 
their diagnosis is X-ray imaging. Tendinopathy is characterized with increased 
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vascularization of the tendon and hence color Doppler and power Doppler are also 
used to assess the increased blood flow of the tendon intratendinously. Although 
MRI and US imaging were widely used as the diagnostic tools in chronic painful 
tendinopathy, studies have reported that MRI and US imaging did not highly 
correlated with the severity of disease (Khan, Visentini et al. 1999; Peers, Brys et al. 
2003). 
As patients with patellar or Achilles tendinopathy may become unwilling to move as 
a result of the longstanding tendon pain, muscle atrophy may occur in calf and thigh 
muscles. The circumferences of calf and thigh bulk have also been used clinically as 
an index of the chronic painful response in tendinopathy (Cook, Khan et al. 2000). 
Regarding functional tests, muscle-tendon function has been used clinically to 
evaluate the strength and endurance of the muscle-tendon complex (Cook, Kiss et 
al. 2004). 
1.5 HISTOPATHOLOGY 
In tendinopathic tendon, yellowish colour is observed rather than the normal glisten 
white color. The macroscopic change of the tendon is due to the deterioration of the 
collagen matrix described as mucoid, myxoid, hyaline, fatty, or fibrinoid degeneration 
(Nichols 1992). The collagen fibers in the pathological tendon are poorly organized 
under the electron scanning microscopy (Jozsa, Reffy et al. 1984; Jarvinen, Jozsa et al. 
1997). Under polarization microscopy, the lost or reduction of birefringence is 
observed in the affected tendon which signifies that the parallel alignment of the 
collagen fibers is lost (Figure 1.1) (Khan, Bonar et al. 1996; Cook, Khan et al. 1997; 
Khan, Cook et al. 1997). 
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Hypervascularity is observed in painful tendon. Increased microcirculation and 
neovascularization were reported in chronic painful Achilles tendinopathy (Richards, 
Win et al. 2005; Knobloch, Kraemer et al. 2006). Besides blood vessels, sprouting of 
nerve fibers was observed in human specimens of chronic painful tendinopathy 
intratendinously (Khan, Cook et al. 1999). 
Infiltration of inflammatory cell is not observed in the clinical samples of 
tendinopathy. However, hypercellularity is detected in the degenerative area of 
tendon (Figure 1.1) (Khan, Cook et al. 1999). Round-nucleated tenoblasts instead of 
the spindle-nucleated tenocytes are observed in the tendinopathic tendon (Astrom 
and Rausing 1995). 
Changes in the composition of the extracellular matrix have been reported in the 
degenerated region of tendon with tendinopathy. Increased collagen type III and type I 
mRNA ratio has been reported (Birch, Bailey et al. 1998). It has been reported that the 
expression levels of collagen type II and III were higher in clinical samples of 
Achilles tendinopathy (Maffulli, Reaper et al. 2006). 
Fibrocartilage and chondrocyte markers were expressed in the clinical samples of 
patellar tendinopathy (Colosimo and Bassett 1990) (Rods, Martens et al. 1978), 
calcific insertional Achilles tendinopathy (Maffulli, Reaper et al. 2006) and rotator 
cuff tendinopathy (Sharma and Maffulli 2005) (Yokota, Gimbel et al. 2005). Recent 
study reported that collagen type II and a transcriptional factor, SRY-box 9 (Sox9), 
were expressed in the rat supraspinatus tendon in an overuse animal model 
(Archambault, Jelinsky et al. 2007). Another report showed that calcium salts 
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concentration was increased in the degenerative tendon as compared with that in the 
normal tendon of human specimens (Riley, Harrall et al. 1996)). Tendon 
calcification observed in human specimens of Achilles and patellar tendinopathy 
were found to be mediated by endochondral ossification (Fenwick, Harrall et al. 
2002). 
1.6 MANAGEMENT OF TENDINOPATHY 
1.6.1 Conservative treatments 
Conservation treatments used in patients aim to reduce inflammatory response of 
tendon. However, as infiltration of inflammatory cells is not observed in chronic 
painful tendinopathy, conservative treatments which aimed to reduce inflammatory 
response are not effective in pain relief (Khan, Cook et al. 1999; Peers and Lysens 
2005). 
Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently used to reduce 
inflammation at the early stage of tendon injury (Almekinders 1990). It was reported 
that NSAIDs administration at the early stage of acute Achilles tendon injury to 
reduce inflammation could effectively relieved pain (Khan, Cook et al. 1999). 
However, the use of NSAIDs to relief pain in tendinopathy has shown deleterious 
effect with increased chance of tendon rupture (Paoloni and Orchard 2005). As 
tendon with tendinopathy has increased neo-vascularization, drugs for regressing the 
vascular structures have been proposed for the treatment of tendinopathy (Ohberg 
and Alfreds。!！ 2003). Indeed, topical Glyceryl Trinitrate was reported to be effective 
in treating Achilles tendinopathy in terms of tendon tenderness and pain scores 
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(Paoloni and Murrell 2007), however, the mechanism of action of Glyceryl 
Trinitrate on tendinopathy was not folly understood (Kane, Ismail et al. 2008). 
Sclerosing agents which cause blood vessel degeneration were also reported to be 
effective in pain relief in Achilles tendon and enable patient to return to 
weight-bearing activities from 3 to 6 months after treatment (Alfredson and Ohberg 
2005; Lind, Ohberg et al. 2006). Polidocanol injection significantly reduced the 
painful response on the patellar tendon and improved the functional outcome of the 
knee in patients with patellar tendinopathy (Alfredson and Lorentzon 2007). As 
nerve fibers are frequently in close proximity to the blood vessels and 
neurotransmitters including Substance P (SP) and calcitonin gene-related peptide 
(CGRP) are also found in blood vessel walls, it is not clear whether the effect of 
these sclerosing agents act on the blood vessels or the nerves (Alfredson, Ohberg et 
al. 2003; Alfredson and Lorentzon 2007). Extracorporeal Shockwave treatment has 
also been reported to be effective in pain relief in calcific tendinopathy (Wang, Ko 
et al. 2007). 
Cryotherapy is often used to reduce blood circulation whereas, massage is 
commonly applied to improve the blood flow in the affected tendon of tendinopathy 
(Rivenburgh 1992). Clinical studies on patellar tendinopathy have shown 
improvement in pain and functional outcome after eccentric exercise (Purdam， 
Jonsson et al. 2004; Roos, Engstrom et al. 2004). 
1.6.2 Surgical treatment 
When conservative treatments fails, surgical operation is the final approach for the 
treatment of chronic painful tendinopathy (Colosimo and Bassett 1990; Panni, 
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Tartarone et al. 2000). During surgical operation, the degenerative tissue of the 
painftil tendon is excised. In general, 6 to 12 months are required for the patients to 
recover after surgery before they can return to sport activities. Some patients can 
resume to 100% performance in sport activities after surgery (Chiara Vulpiani, 
Guzzini et al. 2003). However, it have been reported that 15% - 25% of patients 
have recurrent pain after operation (Paavola, Orava et al. 2000). 
1.7 PATHOPHYSIOLOGY 
1.7.1 Failed healing and differentiation 
The pathogenesis of chronic painful tendinopathy is not clear and is likely to be 
multi-factorial. Failed healing of the tendon due to accumulation of microinjuries in 
overuse of tendon (Kannus 1997)，hypoxia, oxidative stress as well as imbalance in 
cell proliferation and apoptosis, cytokines disturbance, erroneous cell differentiation 
are all the possible factors that have been suggested to be involved in its 
pathogenesis (Goodship, Birch et al. 1994; Yuan, Wang et al. 2003). 
It is speculated that over loading results in microtrauma of tendon. Under normal 
situation, the tendon can repair the injury. However, as the tendon is repeatedly 
overloaded, the microtraumas accumulate and exceed the repair capacity of the 
tendon (Wilder and Sethi 2004). 
It was suggested that excessive oxidative stress might contribute to the pathogenesis 
of tendinopathy (Wang, Wei et al. 2001; Yuan, Murrell et al. 2004). In addition to 
“ 10 
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the degenerative changes, there is an on-going healing process in tendinopathy 
(Sharma and Maffulli 2005). During tendon healing, collagen synthesis increases the 
oxidative stress and reactive oxygen species (ROS) of the tendon. It have been 
reported that excessive ROS production may induce apoptosis of tendon cell (Yuan, 
Wang et al. 2003). Expression of peroxiredoxin 5 (PRDX5), an enzyme that 
eliminates hydrogen peroxide (H2O2) and ROS to reduce oxidative stress, was 
significantly increased in human specimens of tendon degeneration (Wang, Wei et al. 
2001). 
Increased cellularity and vascularity were observed in human specimens of 
tendinopathy, which may contribute to fail healing of chronic painful tendinopathy 
(Jarvinen, Jozsa et al. 1997). Cultured tendon cells from human specimens of 
patellar tendinopathy showed a higher proliferation rate as demonstrated by 
proliferative cell nuclear antigen (PCNA) expression, which may contribute to the 
hypercellularity in tendinopathy in the patellar tendon (Rolf, Fu et al. 2001). 
Increased apoptosis was observed in tendinopathic tendon and was suggested to 
contribute to the pathogenesis of tendinopathy (Yuan, Wang et al. 2003). Increased 
blood vessels and cell density were observed in the painful Achilles tendinopathy 
(Ohberg, Lorentzon et al. 2001; Reiter, Ulreich et al. 2004; Danielson, Alfredson et 
al. 2006). It was suggested that an on-going healing process was involved in 
tendinopathy with angiogenesis within the tendon (Sharma and MaffUlli 2005). 
However, increased vascularity might contribute to the pathogenesis of tendinopathy 
(Ohberg, Lorentzon et al. 2001; Alfredson, Ohberg et al. 2003). 
ECM disturbance may contribute to the pathogenesis of tendinopathy (Chard, 
Cawston et al. 1994; Riley, Goddard et al. 2001). Proteinase such as matrix MMPs 
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and tissue inhibitor of metalloproteinase 1 (TIMP-1) activities are critical in 
maintaining the homeostasis and repair of the tendon (Sharma and Maffulli 2006). 
Increased MMPl and reduced TIMP-1 have been reported in patellar tendinopathy 
(Murphy, Loitz et al. 1994; Dalton, Cawston et al. 1995). MMPl was increased in 
the cultured tendon fibroblast of the patellar tendinopathy under stretching condition 
(Fu, Chan et al. 2002; Yang, Im et al. 2005). It was suggested that imbalance of 
MMPs and TIMP-1 might lead to the degradation of tendon matrix and the 
pathological changes of tendinopathy (Clegg, Strassburg et al. 2007). 
Increased production of cytokines such as cyclooxygenase (COX) -1，COX-2, and 
prostaglandin-E2 (PGE2), as well as active transforming growth factor-betal 
(TGF-betal) were detected in cultured tendon fibroblasts as well as human tendon 
specimens of tendinopathy (Fenwick, Curry et al. 2001; Fu, Wang et al. 2002; Wang, 
Jia et al. 2003). Another study reported that repeated administration of PGE2 led to 
tendon degeneration in the rabbit model (Khan, Li et al. 2005). Vascular endothelial 
growth factor (VEGF) and connective tissue growth factor (CTCF) were also 
suggested to contribute to the initiation of tendinopathy (Nakama, King et al. 2006). 
It was suggested that increased production of cytokines may contribute to the 
pathogenesis of tendinopathy. 
Tendon cells synthesize proteoglycan in response to compressive stimulation 
(Evanko and Vogel 1990; Evanko and Vogel 1993). Previous study has demonstrated 
this in vitro (ref). Under compressive loading, tendon cells underwent metaplasia, 
fibrocartilage and chondrogenic phenotypes were observed (Okuda, Gorski et al. 
1987; Vogel and Koob 1989; Perez-Castro and Vogel 1999). The alternation of 
mechanical stimulation from tensile to compressive loading may favor the 
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transdifferentiation of tendon cells to chondrocytes and contribute to the 
pathogenesis of chronic painful tendinopathy (Ralphs, Benjamin et al. 1998; 
Almekinders, Vellema et al. 2002; Almekinders, Weinhold et al. 2003). Indeed, 
tendon cells have multipotent differentiation potential (Bi，Ehirchiou et al. 2007). 
However, the differentiation potency was reported to be lower than that of bone 
marrow-derived mesenchymal stem cells (Strassburg S 2006). An in vitro study on 
differentiation potential of tendon has reported that tendon cells expressed 
mesenchymal stem cells phenotypes with the expression of mesenchymal 
progenitor-cell markers (de Mos, Koevoet et al. 2007). A unique cell population was 
isolated from human and mouse tendons which expressed the stem cell markers as 
well as properties of stem cells (Strassburg S 2006). Studies suggested that human 
and mouse tendons harbored a cell population with the expression of chondrogenic 
makers and osteogenic markers (Salingcamboriboon, Yoshitake et al. 2003; Bi, 
Ehirchiou et al. 2007; de Mos, Koevoet et al. 2007). It has been investigated that 
such cell population, tendon stem / progenitor cells, was able to regenerate 
tendon-like tissues after extended expansion in vitro and transplantation in vivo (Bi, 
Ehirchiou et al. 2007). Tendon could be differentiated to cartilage and bone during 
tendon healing (Rooney，Walker et al. 1993). As chondrocyte phenotypes and 
matrix calcification were reported in previous studies on the clinical samples of 
tendinopathy (Fenwick, Harrall et al. 2002; Hurt and Baker 2003; Maffiilli, Reaper 
et al. 2006), it is possible that tendon cells may undergo erroneous differentiation, 
and lead to failed healing in tendinopathy as well as calcium deposition in calcific 
tendinopathy. 
Calcium deposition in the mid-substance of the tendon matrix have been reported in 
human specimens of patellar tendon (Lagier and Gerster 1991; Fenwick, Harrall et “ 13 ‘ 
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al. 2002)，Achilles tendon (Fenwick, Harrall et al. 2002)，rotator cuff and 
supraspinatus tendon (Faure, Daculsi et al. 1982; Matsumoto, Ito et al. 2005). It was 
suggested that calcification in calcific tendinopathy was cell-mediated. 
Endochondral ossification was observed with the presence of hypertrophic 
chondrocyte-like cell (Uhthoff 1975; Uhthoff, Sarkar et al. 1976). Calcium salts 
deposition increased in tendon degeneration of human specimens (Riley, Harrall et 
al. 1996). 
1.7.2 Nociception 
Nociceptive substances have been suggested to be the origin of painful response in 
tendinopathy (Khan, Cook et al. 1999). Glutamate (Alfredson and Lorentzon 2002), 
calcitonin gene-related peptide (CGRP) (Bjur, Alfredson et al. 2005), 
prostaglandin-E2 (PGE-2) (Fu, Wang et al. 2002) as well as substance P (SP) 
(Andersson, Danielson et al. 2007) are the nociceptive substances that have been 
reported to increase in tendinopathy. It was demonstrated that glutamate levels and 
their receptors was significantly increased in microdialysis sampling in patellar and 
Achilles tendon of chronic painful tendinopathy (Alfredson, Thorsen et al. 1999). 
Sprouting of CGRP- and SP-positive nerve fibers was reported in tendinopathic 
tissue of Achilles tendon (Bjur, Alfredson et al. 2005). It was also reported that SP 
positive nerve was associated with the painful response of rotator cuff disease and 
tennis elbow as evaluated by visual analogue scale (Gotoh, Hamada et al. 1998; 
Ljung，Alfredson et al. 2004). 
.7.3 Substance P and Calcitonin Gene-Related Peptide 
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Substance P (SP) is a member of tachykinin family. It is a neuropeptide and 
neuromodulator with 11 amino acids, and is widely distributed in the central nervous 
system (CNS) and peripheral nervous system (PNS) (Otsuka and Yoshioka 1993). 
Besides SP, there are four other tachykinins: neurokinin A (NKA), neurokinin B 
(NKB), neurokinin K (NKK), and neurokinin Y (NKY). SP, NKA, and NKB all 
share the same receptors: neurokinin-1 receptor (NK-IR), neurokinin-2 receptor 
(NK-2R), and neurokinin-3 receptor (NK-3R). SP is the first preferred ligand for 
NK-IR, whereas it is the least preferred ligand for NK-2R and NK-3R (Regoli, 
Boudon et al. 1994; Datar，Srivastava et al. 2004). 
SP has a multitude of functions. Besides nociception, SP is also involved in 
inflammatory response by activating neutrophils and eosinophils, as well as 
inducing the production of histamine from mast cells (Roch-Arveiller, Regoli et al. 
1986; Carolan and Casale 1993). SP can also induce vasodilation (Maggi, Giachetti 
et al. 1995)，contraction of iris (Almegard and Andersson 1990)，as well as regulate 
motility and fluid secretion of the gut (Holzer and Holzer-Petsche 1997). 
SP was found to co-localize with CGRP (Gibson, Polak et al. 1984; Wiesenfeld-Hallin, 
Hokfelt et al. 1984). CGRP is a member of calcitonin family with 37 amino acids, 
which is a potent inhibitor of SP degradation (Le Greves, Nyberg et al. 1985). There 
are two forms of CGRP, termed a-CGRP and P-CGRP. Calcitonin receptor-like 
receptor is the receptor of CGRP. To activate the CGRP receptor, calcitonin 
receptor-like receptor (CRLR), the receptor activity-modifying proteins one (RAMP 1) 
is required (Muff, Leuthauser et al. 1998). Similar to SP, CGRP is a neuropeptide and 
neuromodulator, and is widely distributed in the central nervous system (CNS) and 
peripheral nervous system (PNS). CGRP is responsible for migraine pain (Arulmani, 
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Maassenvandenbrink et al. 2004). Besides, CGRP can also regulate glucose level by 
controlling insulin production (Bretherton-Watt, Ghatei et al. 1992). CGRP is a 
vasodilator controlling mucosal blood flow and enhances healing of bowel disease 
(Shen, Pittman et al. 2001). 
SP, substance P-receptor (NK-IR), as well as CGRP have been reported in human 
specimens of tendinopathy (Ljung, Alfredson et al. 2004; Bjur, Alfredson et al. 2005; 
Andersson, Danielson et al. 2008). Both SP and CGRP are sensory nerve markers in 
clinical study of tendinopathy. It have been suggested that SP and CGRP may 
associate with the chronic painful response in tendinopathy (Andersson, Danielson et 
al. 2007). NK-IR, SP preferred receptor, was detected in association with blood 
vessels in both normal and chronic painful Achilles tendon (Ljung, Alfredson et al. 
2004; Andersson, Danielson et al. 2008). Sprouting of SP-positive nerve fiber was 
associated with Achilles tendinopathy (Schubert, Weidler et al. 2005). 
Immunoreactivity against SP and CGRP were observed in the human specimen of 
tendinopathy which was associated with blood vessels in the tendon (Bjur, Alfredson 
et al. 2005). 
Beside nociception, previous studies reported that both SP and CGRP were involved 
in bone metabolism. SP and CGRP were able to induce bone colony formation in vitro 
(Bernard and Shih 1990; Shih and Bernard 1997). CGRP enhanced bone formation 
and reduced bone resorption, by inducing osteoblasts proliferation and inhibiting 
osteoclastogenesis respectively (Wallach, Rousseau et al. 1999; Villa, Dal Fiume et al. 
2003). However, it is still a controversial topic of the effect of SP on bone metabolism, 
since SP could induce both osteoblastic (Gotoh，Hamada et al. 1998; Liu, Jiang et al. 
2007) and osteoclastic activities (Mori, Ogata et al. 1999). 
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1.8 ANIMAL MODELS ON STUDYING TEDNINOPATHY 
1.8.1 Animal models in previous study 
It is beneficial to have animal models for studying the pathogenesis as well as 
treatment of tendinopathy. Horses, rabbits, rats, and mice are the common laboratory 
animal species used in studying tendinopathy (Dahlgren, van der Meulen et al. 2002; 
Chen, Wang et al. 2004; Kersh, McClure et al. 2006; Zantop, Gilbert et al. 2006). 
Rats and mice are more commonly used in view of time, cost and their genetic 
similarity with human (Gibbs, Weinstock et al. 2004). 
Animal models used in previous studies are based on factors which have been 
speculated in the pathogenesis of tendinopathy in clinical studies. Overuse and/or the 
repetitive activities are suspect etiological factor of chronic painful tendinopathy 
(MaffUlli, Wong et al. 2003; Riley 2005). To induce tendinopathy which 
pathologically mimics the clinical observations, artificially induced mechanical 
overloading such as repetitive motion or training exercise was used (Warden 2007). 
However, the tendons of the animals were anatomically adapted to the activities of 
their natural habitat. It is labor intensive to induce overuse injuries in the animal 
model (Moraska A1997). Previous studies induced overuse tendon injuries by running 
the animals on treadmill (Russell, Epling et al. 1987; Carpenter, Flanagan et al. 1998) 
and cyclical loading of the muscle of animal (Nakama, King et al. 2005). The time 
required for successful development of the animal model ranged from 4 weeks up to 4 
months depending on the target tendon (Russell, Epling et al. 1987; Carpenter, 
Flanagan et al. 1998; Nakama, King et al. 2005). These studies have reported 
microtears and expression of growth factors such as vascular endothelial growth factor 
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(VEGF) and connective tissue growth factor (CTCF) which might contributed to the 
initiation of tendinopathy (Nakama, King et al. 2006). Another recent study using an 
overuse rat model has reported increased expression of cartilage and chondrocytes 
markers such as collagen type II and Sox9 (Archambault, Jelinsky et al. 2007). 
Exogenous administration of substances such as cytokines (Stone, Green et al. 1999), 
prostaglandin-El (PGEl) (Sullo, Maffiilli et al. 2001), prostaglandin-E2 (PGE2) 
(Khan, Li et al. 2005)，fluoroquinolones (Simonin, Gegout-Pottie et al. 2000), and 
collagenase (Marsolais, Cote et al. 2001; Chen, Wang et al. 2004) has also been used 
to induce tendinopathic changes in animals in previous studies. Cytokines, PGEl &2 
have been observed in human specimens of chronic painful tendinopathy (Li, Yang 
et al. 2004; Wang, Li et al. 2004). Fluoroquinolones is an antibiotic with reported 
side-effect of tendinopathy (Harrell 1999). Since increased expression of MMPs has 
been observed in patellar tendinopathy and in cultured tendon fibroblasts (Fu, Chan 
et al. 2002; Yang, Im et al. 2005)，collagenase was used to induce tendinopathic 
changes in the Achilles tendon and the patellar tendon in the animals (Marsolais, 
Cote et al. 2001; Chen, Wang et al. 2004). A study using cytokine injection was 
able to induce tendon injury with degenerative changes at early time point, however, 
the degenerative changes was resolved at week 16 (Stone, Green et al. 1999). 
Up-to-now this is no animal model for the study of calcific tendinopathy in the 
patellar tendon. 
1.8.2 Assessment of painful response in animal model 
Despite the fact that pain is the key symptom in tendinopathy and is frequently used 
in the clinical diagnosis and monitoring of treatment of tendinopathy, it is difficult to 
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assess painful response in tendinopathy animal models and there is no standard tool 
for its measurement at present. Previous studies have assessed the painful response 
in animal models by observing their behavioral changes, such as vocalizing, 
guarding, licking, scratching, and lacking of mobility (Molony, Kent et al. 1993; 
Schwartzkopf-Genswein, Stookey et al. 1998; Ko and Naughton 2000). However, 
the behavioral changes may not exactly represent the painful response in the animal. 
Some behavior are inborn but not triggered by stimulus (Le Bars, Gozariu et al. 
2001). 
Functional outcomes such as force platform, footprint analysis, and gait analysis 
have been used as alterative methods for the assessment of functional performance 
and pain. Force platform measures the loading of the injured limb in the animal 
model (Hudson, Slater et al. 2004; Waxman, Robinson et al. 2008). However, the 
gait pattern of the animal is not evaluated. Footprint analysis is a widely used 
method to assess rat sciatic nerve crush injury (Smit, van Neck et al. 2004), which 
focuses on the injured paw of the animal model with static contact to the ground. 
Only the spatial changes of paw are evaluated in footprint analysis. The time interval 
between each stride is not evaluated. Animal gait analysis is a well established tool 
to assess chronic pain in adjuvant-induced arthritis (AA) (Coulthard, Pleuvry et al. 
2002). Not only can it measure the gait pattern, the time interval between each strike 
and the joint angles are also evaluated based on the video recorded. However, gait 
analysis has not been applied for the assessment of pain after tendon injury in 
animals. 
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1.9 AIMS AND OBJECTIVES 
1. To establish a patellar tendinopathic rat model; 
2. To develop a gait analysis method for the assessment of activity-related pain in a 
patellar tendinopathic rat model; 
3. To study the pathogenesis of patellar tendinopathy, with specific emphasis on the 
identification of chondrocyte phenotypes in the collagenase-induced rat patellar 
tendon injury model; 
4. To study the spatio-temporal changes of SP and CGRP expression and their 
association with tendon pain and pathogenesis of tendinopathy. 
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1.10 STUDY PLAN 
Intratendinous injection of collagenase type I was used to induce the patellar tendon 
degeneration in rats. The gait pattern of the rat with patellar tendon degenerative 
injury was evaluated at week 2，4，8，12 and 16 post-injury, as well as at week 16 for 
the saline-injected control. Rat gait video was filmed, and then trimmed. Gait 
parameters including hip forward velocity, stance duration, swing duration, double 
stance duration, and stride duration were evaluated. Afterwards, the patellar tendon 
was harvested and histological analysis including status of inflammation, cellularity, 
and vascularity was determined with hematoxylin and eosin (H&E) staining. 
Polarization microscopy was applied for assessing the organization of collagen 
fibers within the injured tendon as compared to that in the saline-injected control. 
Chondrocyte phenotype was studied by cell morphology with H&E staining and 
immunohistochemistry of Sox9 and collagen type II. Matrix calcification and 
micro-architecture of the mineralized tissues were investigated by von Kossa 
staining, viva-CT imaging and routine histology. The role of endochondral 
ossification in matrix calcification was studied by immunohistochemistry of 
collagen type X. One rat with collagenase injection was kept until week 32 as a long 
study time point for H&E staining and polarization microscopy. Another rat with 
saline injection for week 32 was used as the control. 
The spatio-temporal expression of SP, CGRP, and NK-1 receptor were studied by 
Immunohistochemistry Correlations between different gait parameters and SP 
immunopositivity were then evaluated. 
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Figure 1.1 
Histopathology of clinical specimen of patellar tendinopathy. (A) H&E; (B) 
polarization image. An increase in cellularity and vascularity (arrows) with a 
corresponding loss of collagen birefringence was observed. Optical 
Magnification:400X 
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Unless specified, all chemicals were purchased from Sigma-Aldrich, St Louis, MO. 
2.1 ANIMAL HANDLING 
2.1.1 Reagents 
Hibitane with 95% ethanol, 2.5L 
Hibitane was prepared by diluting 250ml of 5% hibitane concentrate (Regent Medical 
Ltd, SSL International PLC) with 1875ml of 95% ethanol and 375ml double distilled 
water (DDW). 
0.9% saline preparation, IL 
Normal saline was prepared by dissolving 9g of NaCl into IL of MilliQ H2O, and 
sterilized by autoclaving. 
2.5% pentobarbital solution, 100ml 
Pentobarbital was prepared by diluting 12.5ml of 20% sodium pentobarbital solution 
(Dorminal, Alfasan International B.V.，Holland) with 87.5ml of 0.9% sterilized saline. 
2.1.2 Procedures 
Animal Handling 
All laboratory animals were purchased from the Laboratory Animal Services Centre 
of the Chinese University of Hong Kong. This study was approved by the Research 
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Ethic Committee of the Chinese University of Hong Kong. All animals were housed 
in standard rat cage，with five rats per cage. 
Thirty-eight Sprague Dawley (SD, male, 8-week-old) rats with a body weight of 220 
to 250g were used in the present study. At week 2，4，8，12 and 16 after collagenase 
injection, the rats were subjected to gait analysis. Afterwards, they were killed and the 
patellar tendon were harvested for histological and immunohistological studies. There 
were 6 rats for each time point. Rats that were injected with saline instead of 
collagenase for 16 weeks served as saline injection control. One rat injected with 
collagenase and another rat injected with saline for 32 weeks were used for viva-CT 
imaging, followed by general histology. 
To prepare the rats for collagenase injection, they were anesthetized with the 
abdominal injection of 2.5% pentobarbital solution (4.5mg/kg). The knee of the 
treatment side was then shaved using animal hair shaver under aseptic condition. 
On the day before rat gait video recording, rats were anesthetized. Hair around the hip 
joints and knee joints was removed using animal hair shaver. Hip joints, knee joints, 
ankle, and toe of the rat were marked with black ink (Figure 2.1) just before rat gait 
video recording. 
The body weight of each rat was monitored regularly to avoid any adverse effect on 
the rat due to the experimental procedures. The rats were allowed free cage activities 
throughout the study. 
At the indicated time points and after gait recording, the rat was killed with the 
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harvested. 
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2.2 COLLAGENASE-INDUCED PATELLAR TENDON INJURY 
2.2.1 Reagents preparation 
Collagenase preparation 
Collagenase type I from Clostridium histolyticum (Sigma-Aldrich，St Louis, MO) was 
used in the present study. For each injection, 20|il (0.015mg/}il), i.e. 0.3mg of 
bacterial collagenase is required. Collagenase was prepared freshly 3 hours before 
injection. The bacterial collagenase was reconstituted in 0.9% saline, and filtered with 
a 0.22|xm syringe filter (Millipore corporation, Billerica, USA) for sterilization (Chen, 
Wang et al. 2004). The reconstituted collagenase was kept at 4°C until injection. 
2.2.2 Procedures 
Intratendinous injection of collagenase 
The skin over the knee joint was sterilized with hibitane in 95% ethanol before 
injection. The left knee was positioned at 90° for easy visualization of the patellar 
tendon. Twenty microliters of bacterial collagenase was injected intratendinously 
into the patellar tendon with a 30G needle (0.32 mm outer diameter) (Figure 2.2). To 
ensure reproducible and correct injection into the patellar mid-substance, the needle 
was first inserted 2mm below the skin; perpendicular and into the apex of the 
patellar tendon, which was distal to the patellar. Afterwards, the needle was held 
parallel to the patellar tendon, and inserted 4mm further into the patellar tendon. The 
position of the injection site could be confirmed by checking the needle position 
after insertion. Intratendinous position was confirmed by blockage of needle when 
moving upward. Twenty microliters of saline was injected in the left patellar tendon 
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in the saline control group. The knee was released and we waited for about 10 
seconds to allow for the diffusion of collagenase into the patellar tendon before 
removing the needle. 
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2.3 RAT GAIT ANALYSIS 
2.3.1 Rat gait video recording 
To prepare the animal for gait analysis, hair around the hip joints and knee joints 
was removed. Hip joints, knee joints, ankle, and toe were marked with black ink as 
described in procedures of animal handling above. Each rat was guided to run in a 
1.5-meter transparent acyclic plastic walking track (Figure 2.3). A high-speed CCD 
digital video camera (JVC 9600，Japan) was used to record the sagittal view of the 
movement of the hind limbs at 100 Hz. Video clip with three consecutive walking 
steps was classified as a successful trial. For each side view, four successful trials 
were filmed. Hip forward velocity and stride length were measured with the 
calibrated distance. Video capturing of gait pattern was performed for the rats for 
week 2，week 4, week 8，week 12 and week 16 post-collagenase injection groups as 
well as at week 16 for the saline-injection group (n= 6). 
2.3.2 Rat gait video processing 
In each three consecutive walking steps, only the second step was trimmed and 
analyzed with the motion analysis system (Ariel Performance Analysis System, 
USA). Trials with propagation speeds not less than 0.02ni/s were obtained to 
measure the stance duration, swing duration, double stance duration and stride 
duration. Definitions of different gait parameters were shown in table 2.1 (Simjee, 
Pleuvry et al. 2004). Each trimmed video consists of only one stride, starting at the 
time of foot stride and ending at the time of the next foot stride. The X-coordinates 
of the black marker on hip-joint of the first frame and the last frame in each trial 
were obtained. The displacement of the hip-joint was then calculated by subtracting 
CHAPTER 2 METHODOLOGY 
the X-coordinate of the first frame from that of the last frame. Hip forward velocity 
was then calculated by dividing the displacement of the hip-joint by the time of a 
single foot stride. Stance duration, swing duration, stride duration, and double stance 
duration were measured from the rat gait video based on one single foot stride 
according to the definition of each parameter. 
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2.4 PREPARATION OF HISTOLOGICAL SECTIONS 
2.4.1 Reagents preparation 
4% buffered formalin (For Fixation) 
To prepare 4% buffered formalin, lOg of sodium phosphate (NaH2P04) and 16.25g 
of dibasic sodium orthophosphate (NaHaPO*) were dissolved into 250ml of 
formaldehyde and make up to 2.5L with DDW. 
9% formic acid. 2.5L 
9% formic acid was prepared by diluting 225ml of 99.9% formic acid with 2275ml of 
DDW. 
2.4.2 Sample preparation 
The animals were sacrificed at week 2，week 4，week 8, week 12, week 16 after 
collagenase or saline injection (n二 6) for histology and immunohistochemistry. The 
gross observation of the tendon was recorded and the whole patellar tendon was 
harvested. Samples were then washed with 0.9% saline to remove blood and tissue 
derbies. Samples were fixed with 4% buffered formalin at room temperature for over 
night for complete perfusion of the fixative. Fixed samples were then transferred into 
70% ethanol, and kept at room temperature until tissue processing and embedding. 
2.4.3 Coated slide preparation 
Clean glass slides were immersed in acetone for 5 mins, and followed by immersion 
into 2% 3-aminopropyltriethoxysilane (Sigma-Aldrich, St Louis, MO) in acetone for 
15 mins. The coated slides were then washed with distilled water, and dried in an oven 
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for overnight. 
2.4.4 Embedding and Sectioning 
The fixed sample was embedded in paraffin. 5|im-thick longitudinal paraffin 
sections were prepared using soft microtome machine. In order to obtain the tendon 
sections nearby the centre of the tendon, paraffin sections were obtained at 200-|am 
after trimming process. Paraffin sections were then transferred to 3-aminopropyl 
trithoxysilane coated slide, and dried in an oven for over night. For the specimens 
harvested at week 32 post-collagenase or -saline injections, the whole knee joint 
was embedded and sectioned sagittally. 
2.4.5 Decalcification of paraffin section 
The sections for examine the bone-like structures and marrow-like cells in 
hematoxylin and eosin，and immunostaining of collagen type II and X，Sox9, and 
NK-IR were decalcified by immersion in 9% formic acid for 10 mins，followed by 
washing in running water and distilled water for 1 and 2 mins, respectively. 
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2.5 HEMATOXYLIN AND EOSIN (H&E) STAINING 
2.5.1 Reagents preparation 
1% acid alcohol 
One percent of acid alcohol was prepared by adding 5ml of concentrated 
hydrochloride acid (HCl) into 495ml of 70% ethanol. 
Scott's tap water 
To prepare Scott's water, 2g of potassium bicarbonate (KHCO3) and 20g magnesium 
sulphate (MgSCh) were dissolved in ILof DDW. 
1% eosin yellowish 
One percent of eosin yellowish was prepared by dissolving 5g of eosin Y 
(Sigma-Aldrich, St Louis, MO) in 500ml of DDW. 
2.5.2 Procedures 
H&E staining 
Sections were deparaffinized twice with xylene for 5 mins，and immersed in 100% 
ethanol for 3 mins prior to rehydration. Sections were then rehydrated with 90% and 
70% ethanol for 2 min each, respectively. Sections were then incubated in distilled 
water for 1 min and stained with Harris's Hematoxylin (Sigma-Aldrich, St Louis, MO) 
for 10 mins for nuclear staining. The unbound hematoxylin was then removed by 
washing in running tape water, acid alcohol and running tape water for 1 min, 1 sec 
and 1 min, respectively. To enhance the binding of hematoxylin to the cell nucleus, the 
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sections were immersed in Scott's tape water for 3 mins. The sections were then 
incubated in eosin solution for 3 mins for staining of collagen matrix. After all the 
staining procedures, sections were then dehydrated with 70%, 80%, and 90% ethanol, 
10 sec each, and then incubated twice in 100% ethanol for 5 mins each, followed by 
incubation in xylene twice for 5 mins each. The sections were then mounted with 
p-xylene-bis-pyridinium bromide (DPX) (Sigma Aldrich, St Louis, MO) and covered 
with glass cover slid for visualization under the light microscopy (Leica DMRXA2, 
Leica Microsystems Wetzlar GmbH, Germany). 
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2.6 IMMUNOHISTOCHEMISTRY 
2.6.1 Reagents preparation 
IPX and IX phosphate buffered saline (PBS). IL 
lOX PBS was prepared by dissolving 80g of sodium chloride (NaCl), 11.5g of sodium 
phosphate (Na2P04), 2g of potassium hydrogen phosphate (KH2P04), and 2g of 
potassium chloride (KCl) in IL of distilled water. The pH was adjusted to 7.4. The 
PBS solution was then sterilized by autoclaving. 
IX PBS was prepared by diluting lOX PBS with distilled water before use. 
1% bovine serum albumin (BSA) solution 
1% BSA was prepared by reconstituting Ig of BSApowder (Sigma Aldrich, St Louis, 
MO) into 100ml of IX PBS. 
5 % goat or rabbit serum 
Goat or rabbit serum was obtained from the laboratory animals of other studies. 5% 
goat or rabbit serum was prepared by diluting 0.5ml of goat or rabbit serum with 
9.5ml of 1% BSA solution. 
StreptABComplex (DAKO, Glostrup, Denmark) working solution 
StreptABComplex working solution was prepared by diluting 1 |li1 reagent A and 1 \i\ 
reagent B with 998^1 IX PBS. 
2.6.2 Procedures 
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Immunohistochemical staining 
Consecutive sections were deparaffinized twice in xylene for 5 mins each, and 
immersed in 100% ethanol for 3 mins prior to rehydration. Sections were then 
rehydrated with 90% and 70% ethanol for 2 mins each, respectively. For those 
samples that were overstained with hematoxylin, decalcification was then performed 
as described in the "preparation of histological sections for decalcification of 
paraffin section" above. Endogenous peroxidase activities in the sections were 
quenched with 3% hydrogen peroxide in methanol solution for 20 mins at room 
temperature. The sections were then washed for three times with PBS. Antigen 
retrieval was then performed with different methods depending on the primary 
antibodies used (Table 2.2). After rinsing, 5% animal serum was added to the 
sections to reduce the non-specific binding of the primary antibody. Primary 
monoclonal antibodies against different antigens were then diluted with dilution 
buffer at different dilutions (Table 2.2), applied to the sections and incubated at 4°C 
overnight. The slides were then washed with PBS at 3 mins each for four times and 
then blocked with 5% animal serum. The sections were incubated with appropriate 
biotin-conjugated secondary antibody (Table 2.2) at room temperature for 30 mins. 
To reduce the false positive signal, incubated for an hour for horseradish peroxidase 
(HRP)-conjugated secondary antibody was used instead for the in collagen type X, 
collagen type II，Sox9，and NK-IR detection. Sections were then washed with PBS 
for three times at 3 mins each. For the staining with the used of biotin-conjugated 
secondary antibody, sections were then incubated with StreptABComplex (DAKO, 
Glostrup, Denmark) working solution for an hour at room temperature. 3, 
3 ‘ -diaminobenzidine tetrahydrichloride peroxides substrate (DAB) was used to 
develop the color in all sections. The reaction of the DAB substrate was stopped by 
washing the slides with distilled water. Slides were then counterstained in Harris's 
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Haematoxylin, dehydrated with a gradient alcohol and xylene, and mounted with 
DPX (Sigma Aldrich, St Louis, MO). Negative controls for non-specific staining 
were prepared by omitting the primary antibody. All primary antibodies, secondary 
antibodies used, antigen retrieval methods, and positive controls for different 
antigens were shown in Table 2.2. 
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2.7 VON KOSSA STAINING 
2.7.1 Reagents preparation 
1% aqueous silver nitrate solution 
One percent of aqueous silver nitrate solution was prepared by dissolving 1 g of 
silver nitrate (AgNOs) into 100 ml ofDDW. 
5% sodium thiosulfate solution 
Five percent of sodium thiosulfate (Na2S203) solution was prepared by dissolving 2 
g of sodium thiosulfate into 100ml ofDDW. 
0.2% nuclear fast red solution 
0.2% nuclear fast red solution was prepared by dissolving 1 g of nuclear fast red and 
50g of potassium sulphate (K2SO4) into 500ml ofDDW. The solution was boiled for 
5 mins，cooled and filtered before use. 
2.7.2 Procedures 
von Kossa staining 
Sections were deparaffinized twice in xylene for 5 mins each, and immersed in 
100% ethanol for 3 mins prior to rehydration. Sections were then rehydrated with 
90% and 70% ethanol for 2 mins respectively. Slides were then incubated in distilled 
water for 1 min. 1% AgNOa solution was added to the slides for 30 mins under 
illumination in clear glass coplin jar covered with aluminum foil for the 
development of dark brown AgNOs on the mineralized regions of the tendon 
39 
CHAPTER 2 METHODOLOGY 
sections. Slides were then washed under running water for 1 min, followed by 
incubation with 5% Na2S203 solution for 5 mins. Slides were then washed under 
running water for 1 min, and counter stained with 0.2% nuclear fast red solution for 
5 mins for labeling of cell nucleus. Slides were then washed with running water for 
1 min before dehydration. The sections were then mounted with 
p-xylene-bis-pyridinium bromide (DPX) (Sigma Aldrich, St Louis, MO) and 
covered with glass cover slid for visualization under the light microscopy (Leica 
DMRXA2，Leica Microsystems Wetzlar GmbH, Germany). 
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2.8 VIVA-CT SCANNING 
A fan-beam viva CT system (VivaCT40，Scanco Medical AG, Bassersdorf, 
Switzerland) was used to locate the mineralized tissue in the tendon mid-substance 
and to study its 3D structure. The patellar tendon was immersed in 70% ethanol. The 
specimen was scanned with vertical displacement of 30\im for 200 and 350 
consecutive sections, which covered part of the patellar and the whole tibia head, 
respectively. The sections were then 3-dimensionally reconstructed using the built-in 
software. 
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2.9 IMAGE ANALYSIS 
All the histological sections were viewed under a Leica DM5000B microscope and 
photomicrographs were taken using the DFC 490 Digital camera (Leica DMRXA2, 
Leica Microsystems Wetzlar GmbH, Germany). All the image analyses were done 
using the Metamorph image analysis software 6.1 (Universal Imaging; 
Downingtown, PA). The immunopositivity of sox 9, collagen type X，CGRP and 
NK-IR was observable only at 400X optical magnification. Image of H&E under 
polarization microscopy, von Kossa staining, and immunopositivity of collagen type 
II and SP in the injured tendon were examined at 400X optical magnification, and 
semi-quantitative image analysis was preformed as followed. 
2.9.1 Semi-quantitative image analysis of polarization microscopic image, 
collagen type II and von Kossa staining 
To measure the percentage area of loss of birefringence, mineralization area in von 
Kossa staining, immunopositivity of collagen type II staining, microscopic images 
were taken under 12.5 X magnification. 
The percentage area of mineralization area in von Kossa staining and 
immunopositivity of collagen type II staining were evaluated. A "binary" filter was 
applied to the image. Segmented image was then created with "Erode", “Remove 
single pixels", and "Dilate" filter. The segmented image was thresholded and the 
total area of the tendon section was measured. Immunopositive signal for collagen 
Type II was measured by selecting the brown colour with the function "Threshold 
image，，. Immunopositive signal for von Kossa stain was obtained by selecting the 
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dark brown and black colour using the same function. The degree of extracellular 
matrix degeneration was assessed with the H&E images taken under polarization 
microscopy. Under polarization microscope, the dark region indicates loss of 
collagen fibers while the bright region represents well-aligned collagen fibers. The 
percentage area of matrix degeneration of injured tendon was obtained by selecting 
the bright region using the same function as described in the above. 
2.9.2 Semi-quantitative image analysis of SP 
To perform semi-quantitative analyses of immunopositive signal of SP on different 
cell types after tendon injury, photomicrographs were taken at 400X magnification. 
Micrographs from the whole section were used to measure the integrated optical 
density of SP with the exclusion of artifacts, vascular structures and calcified 
regions by selection of the region of interest with the image analysis software. The 
signal which just crossed the edge of the digital view was excluded with the function 
of image analysis software. The positive signal of SP in the brown and dark brown 
colour was selected, using the function "Threshold image" in the image analysis 
software. The integrated optical density of the selected colour was measured 
afterward. 
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2.10 STATISTICAL ANALYSIS 
For the comparison of hip forward velocity, stride length, stance duration, swing 
duration, stride duration, and double sance duration of rats at different time points 
after collagenase or saline injection, analysis of variance (ANOVA) was used 
followed by post-hoc comparison with LSD. 
The integrated optical density of SP，the percentage area of loss of collagen 
birefringence, von Kossa staining and immunopositivity of collagen type II at 
different times after collagenase or saline injection were presented in box plots,. 
Comparison among different time points was made by Kruskal Wallis test, followed 
by post-hoc comparison of different time points after collagenase injection with 
saline control using Mann-Whitney U test. 
The association between the immunopositivity of SP and pain-associated gait 
parameters including hip forward velocity, stride length, stance duration, swing 
duration, stride duration, and double sance duration were done using the Spearman's 
correlation. 
SPSS software version 15.0 (SPSS Inc.,Chicago, IL) was used for all statistical tests, 
p < 0.05 was regarded as statistically significant. 
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Figure 2.1 
Photo showing the intratendinous injection of collagenase into the rat patellar 
tendon. 
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Figure 2.2 
Photo showing the black marks on the hip joint, knee joint, ankle and toe of the rat 
for gait analysis. 
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Figure 2.3 
Photos showing (A) the transparent acyclic plastic walking track and high-speed 
CCD digital video camera for rat gait analysis. (B) During rat gait analysis, rat was 
guided to run in the walking track and the sagittal view of walking motion was 
filmed. 
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Table 2.1 
The definitions of different gait parameters analyzed in the present study. 
Parameters Definition 
Hip forward velocity Velocity of hip joint moving forward 
Stride length Displacement of the toe in one stride. 
Stance duration Time for the limb touching the ground 
Swing duration Time for the limb without touching the ground 
Stride duration Time for the completion of one footstep 
Double stance duration Time for the both limbs touching the ground 
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CHAPTER 3 RESULTS 
3.1 HISTOLOGICAL CHARACTERIZATION OF THE 
COLLAGENASE-INDUCED PATELLAR TENDON INJURY 
RAT MODEL 
3.1.1 Gross observation 
Swelling of the patellar tendons were found on the injured tendons after collagenase 
injection as compared with the saline-injected control (Figure 3.1 A). Tendon 
swelling continued up to week 32 (Figure 3.1G). The tendon appeared glistening 
white in saline-injected control (Figure 3.1A)，whereas it looked yellowish after 
collagenase injection (Figure 3.1B-G). 
Vascularization increased in injured tendons. Blood vessels covered the tendon 
surface and grew from the paratendinous region towards the central core. (Figure 
3.1B-F). However, vascularization was not observed on the surface of the injured 
tendon at week 32 (Figure 3.1G). Bleeding could be observed at week 12 (Figure 
3.IE, arrowheads) and week 16 (Figure 3.IF, arrowheads) post-injury during 
sampling. 
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3.1,2 Hematoxylin and Eosin staining 
In saline-injected control, spindle-shaped tendon cells were observed and were 
embedded in tightly-packed longitudinally-arranged collagen fibers (Figure 3.3). 
Infiltration of inflammatory cell was not observed in saline-injected control. (Figure 
3.3A). Inflammatory cell was not detected in collagenase-injected tendon neither 
(Figure 3.3B-F). After collagenase injection, the extracellular matrix degenerated at 
week 2 (Figure 3.3B), and week 4 (Figure 3.3C). At week 8，injured tendons were 
transiently healed, tendon cells and tendon collagen fibers were aligned though not as 
good as that in the saline-injected control (Figure 3.3D). Alignment of collagen fibers 
of the injured tendons were not improved at week 12 and week 16 as compared with 
week 8 (Figure 3.2D-F). Cell density increased at week 2，and then decreased with 
time till week 8 (Figure 3.3B-D). However, the cell density was increased again at 
week 12 and week 16 (Figure 3.3E-F)，but cellularity was still higher that of 
saline-injected control. Increased vascularity could be observed in all injured tendons 
as compared with that in the saline-injected control (Figure 3.3A-F, arrowheads). 
Interestingly, tendon mineralization was found with over staining of hematoxylin in 
one sample at week 8，and all samples at week 12 and week 16 post-injury (Figure 
3.2D-F). Chondrocyte-like cells, with lacuna space, were first noticed at week 4 
within the tendon collagen matrix, and could still be observed from week 8 to week 
16 (Figure 3.4A-D). They were mainly localized around mineralization regions from 
week 8 to week 16 post-injury (Figure 3.4A-D, CN). Marrow-like cells (Figure 3.5A, 
B) and bone-like structures (Figure 3.6A, B) were observed within some calcified 
nodules of tendon injuries at week 12 and week 16. 
The patellar tendon with collagenase injection failed to heal up to week 32. Intact 
CHAPTER 3 RESULTS 
femoral condoyle (FC)，tibia head (TH) and the sagittal view of the injured patellar 
tendon (PT) with calcific nodules (arrows) could be observed in the knee joint of the 
rat at week 32 (Figure 3.8A). Increased cellularity and vascularity, (Figure 3.3G, 
arrows and arrowheads), loss of birefringence, chondrocyte-like cells as well as 
calcific nodules could still be observed on the decalcified sample at week 32 (Figure 
3.8A-B, E). 
3.1.3 Polarization microscopic observation 
The organization of collagen fibers of the tendon samples were examined under 
polarization microscopy. The percentage area of matrix degeneration in the injured 
tendon was measured by the loss of birefringence. High birefringence was noted in 
the saline-injected control (Figure 3.9A). Collagen fibers were poorly organized at 
week 2 and week 4 after collagenase injection (Figure 3.9B, C). At week 8， 
organization of collagen fiber was improved as demonstrated by the decrease in the 
area with loss of birefringence (Figure 3.9D). Organization of collagen fiber was not 
improved with increased loss of birefringence at week 12 and week 16 
post-collagenase injections (Figure 3.9E, F). Significant increase of percentage area 
of the loss of birefringence was detected at week 2，8，12 and 16 as compared with 
that of the saline-injected control. (Figure 3.10). The percentage area of loss of 
collagen birefringence was significantly higher at week 2, week 8, week 12 and week 
16 as compared to that in the saline-injected control (Overall: p = 0.012 
Kruskal-Wallis test, post-hoc test: p = 0.006 Mann-Whitney U). However, no 
significant difference could be detected at week 4 as compared to that in the 
saline-injected control (p二0.068 Mann-Whitney U) (Figure 3.10). 
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The mineralized region of tendon injuries was examined under polarization 
microscopy. Trabecular bone-like collagen organization was observed within the 
mineralized area at week 12 and week 16 as compared with the rat tibia which served 
as control (Figure 3.7 A-C). 
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3.2 RAT GAIT ANALYSIS TO QUANTITIATE FUNCTIONAL 
CHANGES IN THE COLLAGENASE-INDUCED PATELLA 
TENDON INJURY RAT MODEL 
3.2.1 Hip forward velocity 
The functional outcomes of the rats were measured with rat gait analysis. The hip 
forward velocity was significantly decreased in the collagenase-injected groups as 
compared to that of the saline-injected control (p = 0.027 overall). Significant 
difference was detected at week 2 (p = 0.01)，week 4 (p = 0.05)，week 8 (p = 0.042) 
and week 12 (p = 0.025) compared to saline-injected control. However, no 
significant difference could be detected at week 16 (p = 0.089) as compared to that in 
the saline-injected control (Figure 3.11). 
3.2.2 Stride length 
The stride length was significantly decreased in the collagenase-injected groups as 
compared to that in the saline-injected control (p < 0.001 overall). Significant 
difference could be detected in stride length at week 2 (p < 0.001)，week 4 (p < 
0.001)，week 8 (p = 0.002)，week 12 (p = 0.001) and week 16 (p = 0.003) as 
compared to that in the saline-injected control (Figure 3.12). 
3.2.3 Stance duration 
No significant difference could be detected in stance duration in the 
collagenase-injected groups as compared to that in the saline-injected control (p = 
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0.606 overall) (Figure 3.13). 
3.2.4 Swing duration 
Swing duration was significantly decreased at week 2 (p = 0.019)，week 4 (p = 
0.044)，and week 16 (p = 0.017) injured groups as compared to that in the 
saline-injected control (p = 0.016 overall). No significant difference could be 
detected in swing duration at week 8 (p = 0.726) and week 12 (p = 0.138) as 
compared to that in the saline-injected control (Figure 3.14). 
3.2.5 Stride duration 
No significant difference could be detected in stride duration in the 
collagenase-injected groups as compared to that in the saline-injected control (p = 
0.884 overall) (Figure 3.15). 
3.2.6 Double stance duration 
The double stance duration was significantly reduced in the collagenase-inj ected 
groups as compared to that in the saline-injected control (p 二 0.048). Significant 
difference could be detected in double stance duration between week 2 (p = 0.05) and 
the saline-injected control. However, no significant difference could be detected in 
double stance duration at week 4 (p = 0.135)，week 8 (p = 0.738), week 12 (p = 0.061) 
and week 16 (p = 0.082) as compared to that in the saline-injected control (Figure 
3.16). 
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3.3 CHARACTERIZATION OF MATRIX MINERALIZATION 
IN THE COLLAGENASE-INDUCED PATELLA TENDON 
INJURY RAT MODEL 
3.3.1 von Kossa staining 
The region of mineralization of the collagenase-induced tendon injuries was 
characterized with von Kossa staining. No von Kossa staining was detected in the 
saline-injected control, week 2 and week 4 post-collagenase injections (Figure 
3.17A-C). Tendon mineralization was first observed with high intensity binding of 
sliver nitrate at week 8 (Figure 3.17D)，and were continuously observed at week 12 
(Figure 3.17E) and week 16 (Figure 3.17F) of the injured tendons. The positive 
signals of von Kossa stain were detected in one sample at week 8，and all samples at 
week 12 and week 16. Interestingly, negative signal was detected at the centre of the 
mineralized nodules of the tendon injuries at week 12 and week 16 (Figure 3.17 E，F， 
arrowheads). The percentage area of von Kossa staining was significantly increased 
from week 8 to week 16 as compared to that in the saline-injected control (Figure 
3.18). There was significantly higher percentage area of von Kossa staining at week 
12 and week 16 compared to that in the saline-injected control (overall: p<0.001 
Kruskal-Wallis test, post-hoc test: p二0.004 Mann-Whitney U) (Figure 3.18). 
3.3.2 3-D computed tomographic imaging 
Calcific deposits were observed in the injured tendon at week 32 by viva-CT 
scanning (Figure 3.19). Calcific deposits were observed throughout patellar tendon 
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(Figure 3.19 A, B). Porous structures were observed in some calcific deposits at 
higher magnification (Figure 3.19C). 
3.3.3 Immunochemistry of collagen type X 
The expression of collagen type X，a marker of endochondral ossification was 
evaluated in the samples with immunohistochemistry. Collagen type X expression 
was not detected in the saline-injected control, at week 2 and week 4 (Figure 
3.20A-C). The expression of collagen type X was detected in the chondrocyte-like 
cells around calcified nodules at week 8 (Figure 3.20D). Similar observation was 
found at week 12 and week 16 (Figure 3.20E, F). 
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3.4 CHARACTERIZATION OF CHONDROCYTE 
PHENOTYPES IN THE COLLAGENASE-INDUCED 
PATELLAR TENDON INJURY RAT MODEL 
3.4.1 Immunohistochemistry of collagen type II 
The expression of collagen type II was detected by immunohistochemistry. Collagen 
type II was not observed in saline-injected control (Figure 3.21 A). However, weak 
positive signal was detected in the tendon matrix and tendon cells of the injured 
tendon at week 2 and week 4 (Figure 3.2IB, C). Immunopositive signal was 
observed mainly within the calcified nodule as well as chondrocyte-like cells at week 
8 (Figure 3.2ID) and week 12 (Figure 3.2IE). Similar observation was noted at week 
16 (Figure 3.2IF) after tendon injury. Clear zone was found inside some calcified 
regions at week 16 (Figure 3.2IF). There was significant higher percentage area of 
collagen type II immunopositivity at week 12 and week 16 compared to the that in 
the saline-injected control (Overall: p<0.001 Kruskal-Wallis Test, post-hoc test: 
p=0.004 Mann-Whitney U) (Figure 3.22) 
3.4.2 Immunohistochemistry of Sox9 
Sox9 expression was undetectable in saline-injected control (Figure 3.23A). Sox9 
expression was observed in the tendon cells at week 2 and week 4 (Figure 3.23B, C) 
and was then reduced at week 8 and thereafter (Figure 3.23D). Sox9 was expressed 
mainly in chondrocyte-like cells at week 8 (Figure 3.23D, arrowheads). At week 12 
and week 16 (Figure 3.23E, F, arrowheads), Sox9 were expressed mainly in the 
chondrocyte-like cells surrounding the calcified nodules within the injured tendon. 
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3.5 CHARACTERIZATION OF SP AND CGRP AND THEIR 
ASSOCIATION WITH GAIT PARAMETERS IN THE 
COLLAGENASE-INDUCED PATELLAR TENDON INJURY RAT 
MODEL 
3.5.1 Immunohistochemistry of SP 
Weak positive signal of SP in the tendon cells was detected in the saline-injected 
control (Figure 3.24A). At week 2, the expression of SP was predominantly in the 
tendon cells (Figure 3.24B). At week 4，the tendon cells were stained but the signal 
intensity was reduced as compared with that at week 2 (Figure 3.24B, C). Positive 
signal was further reduced at week 8 (Figure 3.24D). At 12 weeks and 16 weeks, 
weak positive signal of SP was observed in tendon cells (Figure 3.24E, F). However, 
strong positive signal of SP was detected in the chondrocyte-like cells at week 4 
(Figure 3.25A). From week 8 to week 16, positive signal of SP was observed in the 
chondrocyte-like cells, which localized around calcium nodules in the tendon injuries 
(Figure 3.25B-D). SP expression was also expressed strongly in cells embedded in 
the calcium nodules from week 8 to week 16 (Figure 3.26A-C). 
We measured the integrated optical density of the immunopositive signal of SP per 
total tendon area in tendon cells, chondrocyte-like cells, or both (Figure 3.27-29). 
The integrated optical density of immunopositivity in the tendons cells was 
significantly higher at week 2 (p=0.006), week 4 (p=0.006), week 12 (p=0.018), and 
week 16 (p=0.006) as compared with that in the saline-injected control (Overall: 
pcO.OOl Kruskal-Wallis Test, p=0.006 Mann-Whitney U). However, no significant 
difference could be detected in the expression of SP in tendon cells at week 8 as ^ -
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compared with that in the saline-injected control (post-hoc test: p=0.055 
Mann-Whitney U) (Figure 3.27). Expression of SP was significant increased (Overall: 
p<0.001 Kruskal-Wallis Test,) in the chondrocyte-like cells at week 12 (p=0.004) and 
week 16 (p=0.004), and no significant difference could be detected at week 2 
(p=1.00，week 4 (p二0.176) and week 8 (p=0.361) (Figure 3.28). The immunopositive 
signal of SP of both the tendons cells and chondrocytes-like cells at week 2，week 4, 
week 12 and week 16 was significantly higher in the injured tendon as compared 
with that in the saline-injected control (Overall: p<0.001 Kruskal-Wallis Test, 
post-hoc test: p=0.006 Mann-Whitney U). However, no significant difference could 
be detected at week 8 as compared with saline-injected control (post-hoc test: 
p二0.055 Mann-Whitney U) (Figure 3.29). 
3.5.2 Immunohistochemistry ofNK-lR 
The expression ofNK-lR was undetectable in the saline-injected control and week 2 
(Figure 3.30A, B). Positive signal of NK-IR was first observed around the vascular 
structures at week 4 post-injury and could be detected up to week 16 (Figure 3.30C-F, 
arrowheads). NK-IR expression was also detected in the marrow-like cells inside the 
calcific deposits at week 16 (Figure 3.30Q arrowheads). 
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3.5.3 Immunohistochemistry of CGRP 
CGRP expression was not detected in the saline-injected control (Figure 3.31 A). 
Weak positive signal of CGRP was observed in tendon cells at week 2 and week 4 
(Figure 3.3 IB，C). However, positive signal was greatly reduced at week 8，week 12， 
and week 16 in the tendon cells (Figure 3.31D-F). CGRP was also expressed in 
chondrocyte-like cells at week 4 (Figure 3.32A). At week 8，week 12，and week 16， 
CGRP expression was mainly observed in the chondrocyte-like cells localized 
around calcific nodules in the tendon injuries (Figure 3.32B-D). CGRP expression 
was expressed strongly in cells embedded within the calcific nodules from week 8 to 
week 16 (Figure 3.33A-C). 
3.5.4 Correlation of SP expression with gait parameters 
We correlated the immunopositive signal of SP in both tendon cells and chondrocytes 
with the gait parameters (Figure 3.34). The integrated OD of SP in both cell types 
exhibited significant linear inverse relationship with hip forward velocity (r = -0.36, 
p = 0.036), swing duration (r = -0.446，p = 0.007) and stride length (r = -0.342，p = 
0.044) as well as positive relationship with stance duration (r = 0.357, p = 0.035)， 
and double stance duration (r = 0.560, p < 0.001). Stride duration (r=0.218, p = 0.209) 
did not show any significant linear correlation with SP expression (Figure 3.36). 
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Figure 3.1 
Gross appearence of the rat patellar tendon at different time points after 
intratendinous injection of collagenase. (A) saline-injection control; (B) week 2- (C) 
week 4-; (D) week 8-; (E) week 12-，(F) week 16- and (G) week 32- post-collagenase 
injection. For the saline-injection control, the tendon looked glistening white without 
blood vessels on the surface. However, the tendon appeared yellowish with an 
increase in vascualization at week 2 and continued up to week 16 after collagenase 
injection. Bleeding (arrowheads) could be observed at week 12 (E) and week 16 (F) 
post-injury during sampling. No blood vessel was observed at week 32 
post-collagense injection. 
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Figure 3.2 
Photomicrographs showing the histology of patellar tendon at low magnification at 
different time points after intratendinous injection of collagenase. . There was no 
over stained area in (A) saline control, (B) week 2，and (C) week 4. Over stained area 
was first observed at (D) week 8，and the area of over stained region increased at (E) 
week 12 and (F) week 16. H&E staining. Optical Magnification: 12.5X 
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Figure 3.3 
Photomicrographs showing changes of tendon cells and vascular structures at 
different time points after intratendinous injection of collagenase. Spindle-like 
tendon cells embedded within well-aligned tendon matrix were observed in (A) 
saline-injected control. Cellularity (arrows) and vascularity (arrowheads) were 
increased sharply at (B) week 2, and maintained at (C) week 4. However, transient 
healing of tendon was observed at (D) week 8 with reduction in cellularity and 
vascularity. Cellularity and vascularity were then increased again at (E) week 12， 




Photomicrographs showing chondrocyte-like cells in the patellar tendon at (A) week 
4，(B) week 8，(C) week 12, and (D) week 16 after intratendinous injection of 
collagenase. Chondrocyte-like cells (arrowheads), with lacuna space, were first 
noticed at week 4. At week 8，week 12，and week 16, chondrocyte-like cells 
(arrowheads) were mainly localized around calcific nodules (CN). H&E staining. 
Optical Magnification: 400X 
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Figure 3.5 
Photomicrographs showing marrow-like cells inside the calcific deposits. 
Marrow-like cells (arrowheads) inside the calcific deposits (CN) at (A) week 12 and 
(B) week 16 after intratendinous injection of collagenase. H&E staining. Optical 
magnification: lOOX and 400X (inlet). 
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Figure 3.6 
Photomicrographs showing bone-like structures of the calcific deposit of injured 
tendon at (A) week 12 and (B) week 16 after intratendinous injection of collagenase. 
(C) The rat tibia was used as a reference of bone-like alignment. H&E staining. 
Optical magnification: 400X. 
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Figure 3.7 
Polarized images showing the bone-like structures of the calcific deposits at (A) 
week 12 and (B) week 16 after intratendinous injection of collagenase. The rat tibia 
was used as a reference (C) Optical magnification: 400X. 
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Figure 3.8 
Photomicrographs showing the histology of the knee joint and patellar tendon at 
week 32 after intratendinous injection of collagenase. (A) Intact femoral condoyle 
(FC), tibia head (TH) and the sagittal view of the injured patellar tendon (PT) with 
calcific nodules (arrows) could be observed in the knee joint of the rat at 32 week. (B) 
Loss of birefringence of the patellar tendon was observed and did not heal up to 
week 32 post-collagenase injection. (C) Intact femoral condoyle (FC), tibia head (TH) 
and the sagittal view of the patellar tendon (PT) was observed in saline-injected 
control. (D) Well aligned collagen fibers in the saline control were observed under 
polarization microscopy. (E) Chondrocyte-like cells (arrowheads) and calcific 
nodules (CN) could still be observed at week 32. (F) Only tendon cells were 
observed in saline control. H&E staining. Optical magnification: (A-D) 12.5X and 
(E&F) 4Q0X. 
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Figure 3.9 
Photomicrographs showing the loss of collagen birefringence in the patellar tendon 
after intratendinous collagenase injection as observed under polarization microscopy. 
In (A) saline-injected control, tendon collagen fibers were well-organized, and high 
birefringence was observed. However, there was significant loss of birefringence at 
(B) week 2，(C) week 4. At (D) week 8，organization of collagen fiber was improved. 
The organization of collagen fiber not well aligned at (E) week 12，and (F) week 16 
post-collagenase injections. Optical magnification: 400X. 
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Figure 3.10 
Box plot showing the percentage area of loss of birefringence in the tendon samples 
at different time points after intratendinous injection of collagenase. There was 
significant increased in the percentage area of loss of birefringence at week 2，week 8, 
week 12 and week 16 post-collagenase injection as compared to saline-injected 
control (overall: p二0.012 Kruskal-Wallis Test, post-hoc: p=0.006 Mann-Whitney U). 
However, there was no significant difference at week 4 post-collagenase injection as 
compared to that of saline-injection control (p=0.068 Mann-Whitney U). 
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Figure 3.11 
Box plot showing the hip forward velocity at different time points after 
intratendinous injection of collagenase. Significant decrease in hip forward velocity 
was detected at week 2 (p = 0.01), week 4 (p = 0.05), week 8 (p = 0.042) and week 
12 (p = 0.025), (p = 0.027 overall). However, no significant difference could be 
detected at week 16 as compared to that of the saline-injection control (p = 0.089). 
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Box plot showing the stride length at different time points after intratendinous 
injection of collagenase. Significant decrease in stride length could be detected at 
week 2 ( p < 0.001)，week 4 (p < 0.001)，week 8(p = 0.002), week 12 (p = 0.001) and 
week 16 (p = 0.003) as compared to that of the saline-injected control (p < 0.001 
overall). 
CHAPTER 3 — RESULTS 
Trcjinicnl 









 5 W 8 J




• I I I I I value- wek 2 wek.l wek 8 \keek 12 wvek 16 iDjfcled 
Groups 
Figure 3.13 
Box plot showing the stance duration at different time points after intratendinous 
injection of collagenase. No significant difference could be detected in stance 
duration in the collagenase-injected groups as compared to that of the saline-injected 
control (p 二 0.606 overall). 
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Figure 3.14 
Box plot showing the swing duration at different time points after intratendinous 
injection of collagenase. Swing duration was significantly decreased at week 2 (p = 
0.019)，week 4 (p = 0.044)，and week 16 (p = 0.017) post-collagenase injection as 
compared to that of the saline-injected control (p = 0.016 overall). No significant 
difference could be detected in swing duration at week 8 (p = 0.726) and week 12 (p 
=0.138) as compared to that of the saline-injected control. 
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Figure 3.15 
Box plot showing the stride duration at different time points after intratendinous 
injection of collagenase. No significant difference could be detected in stride 
duration in the collagenase-injected groups as compared to that of the saline-injected 
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Figure 3.16 
Box plot showing the double stance duration at different time points after 
intratendinous injection of collagenase. Significant increase in double stance duration 
could be detected at week 2 as compared to that of the saline-injected control 
(p二0.050). However, no significant difference could be detected at week 4 (p = 
0.135)，week 8 (p = 0.738), week 12 (p = 0.061) and week 16 (p = 0.082) as 
compared to that of saline-injected control (overall: p = 0.048). 
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Figure 3.17 
Photomicrographs showing mineralization of the extracellular matrix of the patellar 
tendon at different time points after intratendinous injection of collagenase as 
indicated by von Kossa staining. No positive stain was detected in (A) saline-injected 
control, (B) week 2，and (C) week 4. Matrix mineralization was observed with high 
intensity binding of sliver nitrate at (D) week 8, (E) week 12，and (F) week 16. At 
week 12 and week 16, clear zones (arrowheads) were detected at the centre of the 
mineralized nodules. Optical magnification: 200X. 
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Figure 3.18 
Box plot showing percentage area of von Kossa staining at different time points after 
intratendinous injection of collagenase. Tendon mineralization increased significantly 
at week 12 and week 16 post-collagenase injection as compared to that of 








3-D computed tomographic images showing the presence of calcific deposits in the 
patella tendon at week 32 after intratendinous injection of collagenase as indicated 
by viva-CT scanning. Note the localization of calcific deposits (arrow) in the tendon. 
(A) Oblique view; (B) Calcific deposit at higher magnification. (C) The porous 
structures of the calcific deposits were observed (arrowhead). Bar = 1 [im 
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Immunohistochemistry of collagen type X in the injured tendon at different time 
points after intratendinous injection of collagenase. Expression of collagen type X 
was not detected in (A) saline-injected control, (B) week 2，and (C) week 4. Positive 
signal was expressed intensively in the chondrocyte-like cells (arrowheads) at (D) 
week 8，and chondrocyte-like cells (arrowheads) around calcific nodules (CN) at (E) 
week 12 and (F) week 16. Nuclei were counter stained with hematoxylin. Optical 
magnification: 400X. 
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Immunohistochemistry of collagen type II in the injured tendon at different time 
points after intratendinous injection of collagenase. Expression of collagen type II 
was not detected in (A) saline-injected control. Collagen type II was observed in the 
tendon cells at (B) week 2 and (C) week 4. Positive signals was expressed in the 
chondrocyte-like cells (arrowheads) and calcific nodules (CN) at (D) week 8, (E) 
week 12 and (F) week 16. However, a clear zone was observed at the center of 
calcific nodules in week 16. Nuclei were counter stained with hematoxylin. Optical 
magnification: 400X. 
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Box plot showing the percentage area of collagen type II immunopositivity at 
different time points after intratendinous injection of collagenase. Expression of 
collagen type II was significant increased at week 12 and week 16 post-collagenase 
injection as compared to that of saline-injected control (overall: p<0.001 
Kruskal-Wallis Test, post-hoc test: p=0.004 Mann-Whitney U). 
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Figure 3.23 
Immunohistochemistry of Sox9 at different time points after intratendinous injection 
of collagenase. Sox9 expression was undetectable in (A) saline-injected control. 
Sox9 expression was observed in the tendon cells at (B) week 2 and (C) week 4 
post-collagenase injections, positive signal reduced in the tendon cells thereafter. 
However, Sox9 was expressed in chondrocyte-like cells (arrowheads) at (D) week 8. 
At (E) week 12 and (F) week 16, Sox9 was expressed in the chondrocyte-like cells 
surrounding the calcified nodules (CN). Nuclei were counter stained with 
hematoxylin. Optical magnification:400X. 
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Figure 3.24 
Immunohistochemistry of SP in the tendon cells at different time points after 
intratendinous injection of collagenase. Weak positive signal of SP was detected in 
the (A) saline control. (B) At week 2，the expression of SP was observed intensively 
in the tendon cells. The expression of SP was reduced at (C) week 4 and (D) week 8. 
(E) At week 12 and (F) week 16，weak positive signal of SP was observed in tendon 
cells. Nuclei were counter stained with hematoxylin. Optical magnification: 400X. 
87 
CHAPTER 3 — RESULTS 
丨 
丨 A , 
111 





CHAPTER 3 — RESULTS 
Figure 3.25 
Immunohistochemistry of SP in the chondrocyte-like cells at different time points 
after intratendinous injection of collagenase. Strong positive signal of SP was 
detected on chondrocyte-like cells at (A) week 4. At (B) week 8，(C) week 12，and (D) 
week 16, positive signal of SP was observed on the chondrocyte-like cells 
surrounding the calcium nodules (CN). Nuclei were counter stained with 
hematoxylin. Optical magnification: 400X. 
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Figure 3.26 
Immunohistochemistry of SP in the calcific deposits at different time points after 
intratendinous injection of collagenase. SP was expressed strongly in the cells 
(arrowheads) embedded in the calcific nodules (CN) at (A) week 8，(B) week 12, and 
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Figure 3.27 
Box plots showing the integrated optical density of SP per total tendon area in the 
tendon cells at different time points after intratendinous injection of collagenase. (A) 
The immunopositive signal of SP of tendons cells in week 2 (p二0.006)，week 4 
(p=0.006), week 12 (p=0.018), and week 16 (p=0.006) was significantly higher in the 
injured tendon as compared with that in the saline control (Overall: p<0.001 
Kruskal-Wallis Test). However, no significant difference could be detected in tendon 
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Figure 3.28 
Box plots showing the integrated optical density of SP per total tendon area in the 
chondrocyte-like cells at different time points after intratendinous injection of 
collagenase. Expression of SP was significant increased (Overall: p<0.001 
Kruskal-Wallis Test) in the chondrocyte-like cells at week 12 (p=0.004) and week 16 
(p二0.004)，and no significant difference could be detected at week 2 (p二 1.00)，week 
4 (p=0.176) and week 8 (p=0.361). 
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Figure 3.29 
Box plots showing the integrated optical density of SP per total tendon area in both 
tendon cells and chondrocyte-like cells at different time points after intratendinous 
injection of collagenase. Expression of SP was significant increased for both cell 
types at week 2，week 4，week 12 and week 16 as compared to that in the 
saline-injected control (p<0.001 Kruskal-Wallis Test, p= 0.006 Mann-Whitney U). 
However, no significant difference could be detected in week 8 as compared with 
control (p= 0.055). 
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Figure 3.30 
Immunohistochemistry of NK-IR at different time points after intratendinous 
injection of collagenase. The expression of NK-IR was undetectable in the (A) 
saline-injected control and (B) week 2. NK-IR immunoreaction was observed around 
vascular structures (arrowheads) at (C) week 4，(D) week 8，(E), week 12 and (E) 
week 16. (G) NK-IR expression was also detected in the marrow-like cells inside the 
calcific deposits (arrowheads) at week 16. Nuclei were counter stained with 
hematoxylin. Optical magnification: 400X. 
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Immunohistochemistry of CGRP in the tendon cells at different time points after 
intratendinous injection of collagenase. Immunopositive signal of CGRP was not 
detected in the (A) saline injection control. Weak immunopositive signal of CGRP 
was observed in tendon cells at (B) week 2 and (C) week 4. However, positive signal 
was greatly reduced at (D) week 8，(E) week 12，and (F) week 16. Nuclei were 
counter stained with hematoxylin. Optical magnification: 400X. 
94 










r 、 • 、 - -
 . * N i 々 1 」 - 、 、 
z ^ 、 ： ^
 . “ . V 
’ 岁



















I . . .
 •
 V 、 . 1 
k l j
 ^














































Immunohistochemistry of CGRP in the chondrocyte-like cells at different time points 
after intratendinous injection of collagenase. CGRP was expressed in 
chondrocyte-like cells at (A) week 4. In (B) week 8，(C) week 12, and (D) week 16， 
CGRP was expressed in the chondrocyte-like cells surrounding the calcium nodules 
(CN). Nuclei were counter stained with hematoxylin. Optical magnification: 400X. 
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Figure 3.33 
Immunohistochemistry of CGRP in the calcific deposits at different time points after 
intratendinous injection of collagenase. CGRP expression was expressed in the cells 
(arrowheads) embedded in the calcific nodules (CN) at (A) week 8，(B) week 12，and 
(C) week 16. Nuclei were counter stained with hematoxylin. Optical magnification: 
400X. 
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Figure 3.34 
Scatter plots showing the relationship of integrated optical density of SP per total 
tendon area in the tendon cells and chondrocyte-like cells with different gait 
parameters. Significant linear inverse relationship could be detected between 
integrated optical density of SP and hip forward velocity (p=0.034, r = -0.36), stride 
length (p = 0.044，r = -0.342)，and swing duration (p = 0.007，r =-0.446) as well as 
positive relationship with stance duration (p =0.035, r = 0.357) and double stance 
duration (p < 0.001，r = 0.560). However, no significant linear correlation could be 
detected for (E) stride duration (p = 0.209，r = 0.218). 
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4.1 ESTABLISHMENT OF ANIMAL MODEL FOR STUDY OF 
PATELLAR TENDINOPATHY 
Chronic painful tendinopathy is a degenerative tendon disorder characterized with 
longstanding tendon pain (Cook, Khan et al. 2002; Paavola, Kannus et al. 2002; 
Warden and Brukner 2003). In some cases, calcium depositions were observed in 
tendinopathy, which was characterized as calcific tendinopathy. In tendinopathy, the 
painful response often cannot be relieved after conservative treatments. The 
pathogenesis and origin of pain in tendinopathy remains unclear. An animal model 
with the histopathological characteristics and activity-related painful response is 
advantageous for the study of tendinopathy. The first part of this study aimed to 
establish an animal model for the study of tendinopathy in the patellar tendon. 
Results showed that collagenase injection exhibited many key features of 
tendinopathy including hypercellularity, loss of matrix organization, increased 
vascularity and absence of infiltration of inflammatory cell, which were reported in 
previous clinical studies (Nichols 1992). It was observed that the tendon failed to 
heal with the histopathological characteristics of tendinopathy at week 32 
post-collagenase injection. Transient healing of injured tendon was observed at week 
8 after intratendinous collagenase injection. However, the tendon failed to heal with 
increased cellularity and vascularity after 8 weeks. Results in this study were also 
consistent with previous reports that failed tendon healing due to the accumulation of 
‘ 
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microinjuries has been suggested to be mechanisms of tendinopathy (Cook, Khan et 
al. 2002; Riley 2005; Maffulli, Reaper et al. 2006). 
Structures in the knee joint surrounding the patellar tendon were intact at week 32 
after collagenase injection, and there was no sign of injury in the tendon at week 16 
and 32 in the saline-injected controls. This indicated that the problem associated with 
leakage of collagenase, if any, did not have any adverse effect on other structures of 
the knee joint and the changes observed in the patellar tendon was due the 
collagenase injection intratendinously. 
Overuse and/or repetitive activities (Russell, Epling et al. 1987; Carpenter, Flanagan 
et al. 1998; Archambault, Jelinsky et al. 2007), as well as introduction of exogenous 
substances (Stone, Green et al. 1999; Simonin, Gegout-Pottie et al. 2000; Sullo, 
MaMl i et al. 2001) in tendon had been used to induce tendon injuries for studying 
tendinopathy. Compared to the development of tendinopathy using overuse and/or 
repetitive activities or injection of PGEl and PGE2，the method use in this study, 
with the use of collagenase is simple, as only a single injection is required (Sullo, 
Maffulli et al. 2001; Khan, Li et al. 2005). Overuse was suggested as a possible 
factor in the etiology of tendinopathy, and animal model induced with overuse 
tendon injury has been established in rat (Scott, Cook et al. 2007) and rabbit (Hart, 
Kydd et al. 1999) on supraspinatus tendon and Achilles tendon. However, the 
pathological changes of the overused tendon could be recover with rest (Jelinsky, 
Lake et al. 2008). Such animal model may not feasible for studying innervations of 
tendinopathy. Cytokines injection into patellar tendon of the rabbit was reported to 
induce tendon injury with degenerative changes at early time point, however, the 
degenerative changes were resolved at week 16 (Stone, Green et al. 1999), whereas, 
Wi 
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in this study the rat model reported the failed healing till week 32 post-collagenase 
injection, which facilitates study of the treatment of tendinopathy in the future. 
Collagenase injection have been used in tendinopathy animal model (Stone, Green et 
al. 1999; Marsolais, Cote et al. 2001; Chen, Wang et al. 2004), however, calcific 
deposition has not been reported in previous studies with the collagenase injection. In 
addition, study on the patellar tendon injury in the rat model after collagenase 
injection has not been reported in previous studies. The animal model reported the 
failed healing and matrix degeneration with calcific deposition in the rat patellar 
tendon, and the calcification in tendon injury was reproducible in the present study. 
Results suggested that collagenase-induced tendon degeneration in rat patellar tendon 
is a good model for the study of the pathogenesis and interventions on calcific 
tendinopathy of patellar tendon. 
4.2 PATHOGENESIS OF TENDINOPATHY IN THE PATELLAR 
TENDON 
After the establishment of the collagenase-induced tendon degeneration rat model, 
the pathogenesis of tendinopathy was studied in this rat model. Disorganization of 
collagen matrix was similar to that of the human specimens of tendinopathy 
(Jarvinen, Jozsa et al. 1997; Khan, Cook et al. 1999). It was suggested that ECM 
degradation might contributed to the onset of pathogenesis of tendinopathy (Riley, 
Goddard et al. 2001; Clegg，Strassburg et al. 2007). Loss of tendon cells orientation 
due to tendon matrix degradation was suggested to disturb collagen synthesis, 
maintenance, and remodeling of ECM of tendon (Birk and Zycband 1994; O'Brien 
1997). It have been reported that concentration of calcium salts was increased in 
degenerative tendon, and might contribute to the pathogenesis of tendinopathy (Riley, 
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Harrall et al. 1996). 
Increased vascularity and cellularity were observed throughout the study after 
intratendinous collagenase-injection as part of the repair response to 
collagenase-induced injury. The tendon cells proliferated and produced cytokines and 
growth factors for collagen synthesis (Dahlgren, Mohammed et al. 2005; Sharma and 
Maffulli 2006). Cell density increased in tendon repair, which enhanced synthesis of 
collagen in the injured tendon. During repair, the oxygen demand for collagen 
synthesis increased. Angiogenesis and innervations thus occurred to meet the 
increased demand of nutrients and oxygen in collagenase-induced tendon injury 
(Gelberman, Chu et al. 1992). 
Sox9 as well as collagen type II were expressed in tendon cells at week 2. From 
week 4 to week 16，sox9 and collagen type II were expressed in chondrocyte-like 
cells. Collagenase injection might lead to ECM disturbance of the tendon in the rat 
model (Hsu, Hsu et al. 2004). ECM of the tendon provides tendon cells a substrate 
for adhesion, cell-cell communication and modulates the response of tendon cells to 
tensile loading (McNeilly, Banes et al. 1996). ECM also affects the growth and 
differentiation of the cell in connective tissue (Chiquet 1999). Studies have been 
demonstrated that tendon cells might adapt to compressive stimulation and 
synthesized proteoglycan, such alternation might contribute to the pathogenesis of 
tendinopathy (Evanko and Vogel 1993; Almekinders, Vellema et al. 2002). Under 
compressive loading, tendon cells differentiated into fibrocartilage (Okuda, Gorski et 
al. 1987; Vogel and Koob 1989; Perez-Castro and Vogel 1999). Based on the 
histological observation, it was speculated that ECM disturbance might alter the 
mechanical stimulation to the tendon cells, which might favor the transdifFerentiation — 
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of tendon cells to chondrocytes. It has been suggested that tendon cells might 
differentiate into fibrocartilage to initiate matrix mineralization (Uhthoff, Sarkar et al. 
1976). Previous studies indicated that tendon cells had multipotent differentiation 
potential (Bi, Ehirchiou et al. 2007; de Mos, Koevoet et al. 2007). An in vitro study 
on differentiation potential of cells isolated from tendon has reported that tendon 
cells expressed mesenchymal stem cells markers and phenotypes (de Mos, Koevoet 
et al. 2007). However, the differentiation potency might be lower than that of bone 
marrow-derived mesenchymal stem cells (Strassburg S 2006). Bi et al. also reported 
the presence of a unique cell population within the human and mouse tendons which 
expressed the markers as well as properties of stem cell. Such cell population, tendon 
stem / progenitor cells, were able to regenerate tendon-like tissues after extended 
expansion in vitro and transplantation in vivo (Bi, Ehirchiou et al. 2007) 
4.3 ENDOCHONDRAL OSSIFICATION IN CALCIFIC 
TENDINOPATHY OF THE PATELLAR TENDON 
The results showed the presence of chondrocyte-like cells inside the tendon, which 
was not site specific, after collagenase injection. This was indicated both by 
morphological observation and immunohistochemistry. Chondrocyte-like cells with 
lacuna space, expression of Sox9 and collagen type II were first observed at week 4. 
The presence of chondrocyte phenotypes were also reported in Achilles tendon and 
patellar tendon in human specimens of tendinopathy (Fenwick, Harrall et al. 2002; 
Maffulli, Reaper et al. 2006), suggested that ectopic chondrogenesis might contribute 
to the pathogenesis of tendinopathy. It was also demonstrated that a clear zone was 
observed within the positive region of collagen type II within the calcific nodules at 
week 16 after collagenase injection. The presence of clear zone could be explained m — 
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by the normal bone formation process, in which collagen type II was degraded by 
MMPs (Blumer, Longato et al. 2008)，and collagen synthesis was reverted from type 
II to type I (Toole and Linsenmayer 1977). It is possible that within calcific nodules 
of collagenase-injected tendon collagen synthesis might be switched, and clear zone 
was seen within positive region of collagen type II. 
From 8 week to 16 week, chondrocyte-like cells could be observed and localized 
around calcific nodules of the injured tendon. Calcific nodules were indicated by von 
Kossa staining. Positive signal of von Kossa staining was first observed in the 
injured tendon at week 8 and then in all samples at week 12 and week 16 after 
collagenase injection. Calcific nodules could still be observed up to week 32 
post-collagenase injection. The results were further suggested that the calcific 
nodules exhibited bone-like characteristics. Under polarization microscopy, 
trabecular bone-like collagen alignment was observed at week 12 and week 16 in the 
decalcified sections. Within some calcific deposits, marrow-like cells were noted. In 
viva-CT image, calcific deposits were detected throughout the injured tendon. Porous 
structures were demonstrated by viva-CT imaging, which were observed inside the 
calcific deposits at week 32 after collagenase injection. Previous studies also 
reported calcific regions with bone-like structures inside the tendon in clinical 
samples (Archer, Bayley et al. 1993; Fenwick, Harrall et al. 2002). 
It was suggested that collagenase-induced tendon injuries with the expression of 
collagen type X were underwent endochondral ossification which was mediated by 
chondrocyte-like cells in the injured tendon. Since the expression of collagen type X 
were observed in the calcific nodules at week 8，week 12 and week 16. At the 
terminal stage of chondrocytes differentiation, the hypertrophic chondrocytes 
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synthesize collagen type X to initiate endochondral ossification (Shen 2005). 
Collagen type X stimulates the influx of calcium ion into the matrix vesicles, which 
are roundish bodies that can be observed in uncalcified matrix of osteiod tissue, for 
rapid accumulation of calcium ion during the mineralization process, and promotion 
of calcification during bone formation (Anderson 1969; Sela, Bab et al. 1981; Kirsch 
and Wuthier 1994). At the terminal stage of endochondral ossification, apoptosis of 
chondrocytes and vascularization occurred, allowing for the development of bone 
marrow cavity. That the bony deposits inside the tendon was mediated by 
endochondral ossification was also reported in human specimens of Achilles and 
patellar tendinopathy (Fenwick, Harrall et al. 2002). However, one study has 
reported no expression of collagen type II and alkaline phosphatase in clinical 
samples of calcific rotator cuff tendinopathy , and it was suggested that some cases 
of calcific tendinopathy was not cell-mediated (Archer, Bayley et al. 1993). 
4.4 RAT GAIT ANALYSIS FOR THE ASSESSMENT OF PAIN 
AFTER INTRATENDINOUS COLLAGENASE INJECTION 
Chronic musculoskeletal conditions, except osteoporosis, are commonly presented 
with pain. The painful response of arthritis has been widely investigated in 
adjuvant-induced arthritis (AA) animal models (De Castro Costa, De Sutter et al. 
1981; Coulthard, Pleuvry et al. 2002; Simjee，Pleuvry et al. 2004). However, there 
has been no method for the assessment of pain in chronic tendon injury in animals. In 
the current study, animal gait analysis was used to quantify the activity-related pain 
in the rat model with collagenase-induced tendon injury. Hip forward velocity, stride 
length, and swing duration were significantly decreased while double stance duration 
was significantly increased after collagenase injection in this study. These gait 
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changes might be due to the painful response on the injured limb and the animal thus 
preferred to walk at a slower speed and shorter stride length. As tendon injury was 
only induced in the left limb, the animal might shift the weight on the injured side to 
the contralateral side together with the decrease in walking speed, and these in terms 
might lead to decreased swing duration and increased double stance duration during 
walking. 
The results in this study were consistent with Coulthard's team findings that forward 
velocity and stride length were significantly reduced, and double stance duration was 
significantly increased in the chronic pain model of AA (Coulthard, Pleuvry et al. 
2002). In this study, it was reported that there was no significant difference in stance 
duration and significant decreased in swing duration after induction of tendon 
injuries, whereas Coulthard's group reported stance duration was significant 
decreased and there was no significant difference in swing duration. The differences 
might be due to different types of injury and location as well as the duration of study. 
Collagenase rather than adjuvant was use to induce injuries in the rat model in this 
study. Moreover, this study measured the activity-related pain for up to 16 weeks 
while the pain was measured for 14 days only in Coulthard's study. In this study, the 
gait pattern was measured only once just before sample collection for histological 
and immunohistochemical analysis. However, the gait pattern was monitored 
longitudinally for 14 days which might have significant training effect on the animal 
and hence affected the gait pattern (Coulthard, Pleuvry et al. 2002). 
The correlation analysis of SP expression with the gait parameters was performed in 
this study, and the results showed that the hip forward velocity, swing duration, stride 
length, and double stance duration were found to significantly correlate with the 
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expression of SP in collagenase-induced tendon injury. SP expression has been 
implicated in the mediation of painful response in tendinopathy (Andersson, 
Danielson et al. 2007) and its expression has been reported to be highly correlated 
with painful response (Schubert, Weidler et al. 2005; Alfredson and Lorentzon 2007; 
Andersson, Danielson et al. 2007). Results showed a biphasic pattern of 
immunopositivity of SP after collagenase-induced tendon injury, and same pattern 
was observed in the double stance duration in the gait analysis. The association 
between the integrated optical density of SP per total tendon area and double stance 
duration showed the highest correlation. It was suggested that double stance duration 
is the parameter which highly correlated with the tendon pain after collagenase 
injection. 
4.5 SPATIAL AND TEMPORAL EXPRESSION OF SP, CGRP, 
NK-IRAND THEIR POSSIBLE ROLES IN THE 
PATHOGENESIS OF TENDINOPATHY 
In the current study, SP and CGRP were expressed intensively in the tendon cells in 
early time point and in the chondrocyte-like cells in the later time point after 
collagenase injection into the patellar tendon intratendinously. SP and NK-IR were 
involved in the mechanotransduction of chondrocytes in human articular cartilage 
(Millward-Sadler, Mackenzie et al. 2003). Mechanical stimulation is important in the 
maintenance of the chondrocytes behavior in cartilage (Salter, Millward-Sadler et al. 
2002). However, the role of SP and CGRP in chondrocytes in this study was not fully 
understood. 
In this study, it was showed the expression of SP and CGRP could be detected in the 
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cells embedded in and around calcific nodules of the injured tendon. SP has been 
reported to stimulate osteoclasts activities and resulted in bone resorption. On the 
other hand, SP was also demonstrated to increase bone colony formation in vitro 
(Shih and Bernard 1997). It indicated that SP has both osteogenic and 
osteoclastogenic effects (Mori, Ogata et al. 1999). CGRP enhanced bone growth by 
stimulating osteoblastic activities and inhibiting bone resorption (Zaidi, Chambers et 
al. 1987; Bernard and Shih 1990). Recent study reported that SP enhanced bone 
formation in the presence ofNK-lR in vitro (Goto, Nakao et al. 2007). SP could also 
stimulate the proliferation of stromal cell, and increased intracellular concentration of 
calcium (Hiramoto, Aizawa et al. 1998). Results of the current study showed that 
NK-IR expression was observed in the marrow-like cells within the tendon injuries 
at week 16 after collagenase injection. It was hypothesized that increased SP and 
CGRP expression within calcific area might contribute to the calcification process in 
tendon injuries after collagenase injection. 
It was demonstrated that NK-IR expression was first observed in cells around the 
vascular structures at week 4 and up to week 16. Similar finding has been reported in 
previous study in the painful Achilles tendon and patellar tendon of human 
specimens (Forsgren, Danielson et al. 2005). However, nerve fibers as well as 
NK-IR expression in nerve fibers were not detected. It was speculated that nerve 
fibers in rat tendons might be too small for the detection of NK-IR expression as 
compared with that in human specimens in previous studies. 
In this study, NK-IR was not detected in the tendon cells and chondrocyte-like cells 
in the injured tendon. This was different from the findings reported by Forsgren's 
group (Forsgren, Danielson et al. 2005). It might be due to different methods of 
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sample processing and antigen retrieval. Besides, different primary antibodies were 
used which might affect the sensitivity of antigen detection. 
In this study, it was indicated that the expression of SP and CGRP in the injured 
tendon throughout the study period. It has been proposed that nerve plasticity might 
contribute to the early healing process of the injured tendon (Burssens, Steyaert et al. 
2005). SP- and CGRP- positive nerves have been reported in the early healing 
process of the rat Achilles tendon rupture (Ackermann, Li et al. 2003). Paratendinous 
administration of SP enhanced early tendon healing in rat Achilles tendon after 
induction of acute injury (Burssens, Steyaert et al. 2005). Several studies reported 
that SP and CGRP might have proliferative and neuroinflammatory roles in 
soft-tissue healing (Salo，Bray et al. 2007; Bring, Reno et al. 2008). Study showed SP 
and CGRP positive nerves observed in healing wound, suggested that sensory nerves 
may enhance circulation of small blood vessels during wound healing process (Brain 
1997). Exogenous administration of SP increased fibroblasts proliferation, tendon 
matrix organization and angiogenesis in the early healing phases after soft tissue 
injury (Brain 1997; Burssens, Steyaert et al. 2005). Beside, it was suggested that SP 
and CGRP may contribute to pro-inflammatory response in wound healing (Ansel, 
Armstrong et al. 1997). It have been reported that SP and CGRP significant increased 
the secretion of proinflammatory cytokines including interleukin (IL)-ip, -6, and 
TGF-a in cultured human dental pulp fibroblasts (Yamaguchi, Kojima et al. 2004). 
The expression of both SP and CGRP might play a role in the tendon tissue repair in 
early time point, which might then contributed to the nociception and the 
pathogenesis of tendinopathy in the advanced stage of tendon injuries. 
It have been suggested that proinflammatory cytokines such as IL-1 and tumor 
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necrosis factor (TNF) could enhance MMPs production and reduced TIMPs 
production and eventually caused tendon matrix disturbance (Murphy, Loitz et al. 
1994; Cawston 1995; Dalton, Cawston et al. 1995; Tsuzaki, Guyton et al. 2003). In 
addition, SP and CGRP were also reported to induce the mRNA expression ofMMPl 
and MMP3 in the explant culture of paratendinous tissue and mid-substance portion 
of the Achilles tendon of rabbits (Hart, Kydd et al. 1999). In this study, it was 
speculated that SP and CGRP expression in the injured tendon might contribute to 
the MMPs expression, and which might possible to contribute to the pathogenesis of 
tendinopathy. 
4.6 CORRELATION OF SP AND NK-IRIMMUNOREACTION 
WITH GAIT PARAMETERS 
Chronic tendon pain depends on the production of nociceptive substances by the 
pathological tissues, and the availability of nerve endings to pick up the signals of 
pain (Lian, Dahl et al. 2006). In this study, the results showed that gait changes were 
associated with SP expression in the injured tendon. However, NK-IR could only be 
detected around vascular structures from weeks 4 to weeks 16 after 
collagenase-injection. Study have been suggested that availability of receptors as 
well as the concentration of ligands were also the important factors for endogenous 
tachykinins acting on specific type of neurokinin receptors (Regoli, Boudon et al. 
1994). It have been reported that NK-2R was involved in nociception the normal and 
inflamed joint in the rat model (Neugebauer, Rumenapp et al. 1996). It was 
speculated that NK-2R and NK-3R might also contribute to activity-related gait 
change in the rat model in the present study. 
m 
CHAPTER 4 DISCUSSION 
4.7 SIGNIFICANCE 
This was the first study to generate tendinopathy in the patellar tendon using 
collagenase injection. The animal model with respect to the clinical histopathological 
changes was successfully characterized and has followed up the changes for 32 
weeks. Previous animal models of tendinopathy induced by various methods have 
been followed up for a maximum of 26 weeks only. 
Calcific deposits in addition to matrix degeneration and failed healing were 
consistently observed in the rat model in the current study. This observation has not 
been reported in previous studies and it was suggested using this model for studying 
the pathogenesis as well as the intervention of calcific tendinopathy of patellar 
tendon. 
The first method for the assessment of activity-related painful response was 
established after collagenase injection into the patellar tendon. This would facilitate 
further intervention studies on activity-related pain in tendinopathy. 
All the previous studies on the expression of SP, CGRP and NK-IR were based on 
clinical samples of different degrees and duration of symptoms (Ljung, Alfredson et 
al. 2004; Bjur, Alfredson et al. 2005; Andersson, Danielson et al. 2008). There is no 
controlled study on the spatial and temporal patterns of SP, CGRP and NK-IR 
expression in a tendinopathy animal model, yet the information is important for the 
understanding of their roles in the pathogenesis. In this study, it was reported the 
increased expression of SP and CGRP in tendon cells, chondrocytes and calcific 
deposits, indicating that these neuropeptides could be locally produced by 
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non-neuronal cells and their expression in these cell types might be associated with 
the roles of cell proliferation, matrix degeneration, mechanotransduction and bone 
formation as reported in previous studies (Ansel, Armstrong et al. 1997; Brain 1997; 
Datar, Srivastava et al. 2004; Burssens, Steyaert et al. 2005) and hence contributed to 
the pathogenesis of tendinopathy. 
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4.8 LIMITATIONS OF PRESENT STUDY 
It have been reported that NK-IR was detected around nerve fibers in human 
specimens of tendinopathy (Forsgren, Danielson et al. 2005; Andersson, Danielson et 
al. 2008). However, NK-IR positive nerve fibers have not been observed in the 
tendon samples in the present study. While it was suggested the nerve fibers might be 
too fine to be detected, it needed to be confirmed with the use of specific nerve 
markers. The use of different sample processing and antigen retrieval methods should 
also be performed to confirm the expression of NK-IR in the vascular structures. 
The semi-quantitatively measurement of the integrated OD of SP was performed, and 
which was correlated with the gait parameters, it was suggested that the 
semi-quantitatively measurement as well as the correlation analysis should be 
performed for CGRP in future studies. 
In this study, only the correlation study of the gait parameters with the expression 
level of SP was performed. In order to confirm that the changes in the gait pattern 
of the rats were due to painful response induced by collagenase injection or mediated 
by SP, reversal of gait pattern after administration of analgesic or SP blocker should 
be demonstrated. 
114 
CHAPTER 4 DISCUSSION 
4.9 FURTHER STUDY 
Rat gait analysis should be performed before and after the administration of 
analgesic to further confirm the causal relationship between gait change and tendon 
pain. In addition, SP blockers could also be used to study the casual relationship 
between gait change and tendon pain after induction of tendon injuries with 
collagenase. 
Expression of SP and CGRP were observed throughout the study period in the 
injured tendon. The role of SP and CGRP in tendon healing and tendinopathy could 
be further investigated in the future. 
Calcitonin gene-related peptide (CGRP) (Danielson, Alfredson et al. 2006) was also 
extensively reported in tendinopathy. The influences of CGRP in correlation to 
activity-related gait change will be evaluated in the future. 
It was speculated that NK-2R and NK-3R might involve in the nociception in the 
injured tendon in current study. The role ofNK-2R and NK-3R in the nociception in 
tendinopathy should be evaluated in the future. 
While the presence of chondrocyte phenotypes and ectopic ossification in the calcific 
tendinopathy rat model was demonstrated, however, the mechanism is not clear. It 
was hypothesized that such histopathological changes were due to erroneous 
differentiation of healing tendon cells which led to these changes. Future studies 
should study the molecular mechanisms causing these changes. 
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4.10 CONCLUSIONS 
In conclusion, an animal model with the histopathological features of the calcific 
tendinopathy in the patellar tendon in rat was established. This animal model 
exhibited the key histopathological characteristics of tendinopathy. Transient healing 
with the improvement of collagen fiber alignment was observed at week 8. However, 
the condition deteriorated and the tendon failed to heal till 32 weeks post-injury in 
terms of gross observation, cellularity, and vascularity as compared with that in 
saline-injected control. Tendon calcification was demonstrated with von Kossa 
staining after induction of tendon injury. Marrow-like cells and bone-like collagen 
alignment were observed under polarization microscopy at week 12 and week 16. 
Bone formation within the injured tendon was further confirmed with the presence of 
porous structures by viva-CT scanning. 
Collagen type X was observed within the calcific nodules from week 8 to week 12, 
which was surrounded by chondrocytes-like cells. Chondrocytes observed around 
calcification nodules from week 8 to week 16 were confirmed with the presence of 
lacuna space, and the expression of Sox9 and collagen type 11. It was reported that 
the calcification process in the current animal model was mediated by endochondral 
ossification. 
SP and CGRP expression were observed in the tendon cells at early time point, then 
expressed intensively in chondrocytes and cells embedded within the calcific area 
from weeks 8 to weeks 16. Present study suggested that SP and CGRP expression 
might contribute to the healing process in early time point, which might then 
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contribute to the pathogenesis of calcific tendinopathy thereafter. 
The first method for the assessment of activity-related painful response in the 
tendinopathy rat model was established after collagenase injection. The functional 
changes in the rat model were associated with the SP expression in the injured tendon. 
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Title: Chondrocyte Phenotype and Ectopic Ossification in 
Collagenase-induced Tendon Degeneration 
Summary 
We reported spontaneous chondrocyte phenotype and ectopic ossification in a 
collagenase-induced patellar tendon injury model. Collagenase or saline was injected 
intratendinously in one limb. Patella tendon was harvested for assessment at different 
times. There was increase in cellularity, vascularity and loss of matrix organization 
with time after collagenase injection. The tendon did not heal up to week 32. Ectopic 
mineralization as indicated by von Kossa staining started from week 8. Tendon 
calcification was mediated by endochondral ossification as demonstrated by 
expression of type X collagen. viva-CT imaging and polarization microscopy both 
showed the characteristic bony porous structures and collagen fiber arrangement, 
respectively, in the calcific regions. Marrow-like cells and blood vessels were 
observed inside calcific deposits. Chondrocyte-like cells as indicated by morphology, 
expression of type II collagen and sox 9 were seen around and embedded inside the 
calcific deposits. Fibroblast-like cells expressed type II collagen and sox 9 at earlier 
times, suggesting that erroneous differentiation of healing tendon fibroblasts may 
account for failed healing and ossification in collagenase-induced tendon 
degeneration. As this animal model replicates key histopathological changes of 
calcific tendinopathy, it can be used as a model for the study of its pathogenesis at 
the patellar tendon. 
Word count: 198 




Chronic insertional tendinopathy is a poorly characterized tendon degenerative 
disorder that is extremely common in athletes as well as in the general population. 
Despite its prevalence, its underlying pathogenesis is poorly understood and 
treatment is usually symptomatic. Calcific tendinopathy is also a degenerative 
disorder of tendon with calcium deposits in the mid-substance. It has a similar 
pattern of occurrence and is particularly common with some degenerative 
tendinopathy such as that in patella (Fenwick et al. 2002; Lagier and Gerster 1991), 
Achilles (Fenwick et al. 2002), rotator cuff and supraspinatus tendons (Matsumoto et 
al. 2005; Faure and Daculsi, 1983). 
Histologically, tendinopathic tissue showed a non-healing status characterized by 
increase in cellularity, proteoglycan deposition, particularly the oversultated form, 
collagen matrix degradation, matrix metalloproteinase 1 (MMPl) and tissue inhibitor 
ofmetalloproteinase 1 (TIMP-1) and gelatinolytic activity (Fu et al. 2002a, b; 2007; 
Jarvinen et al. 1997; Khan et al. 1999，Riley 2005). Recently, sprouting of 
substance-P-positive nerve fibers were reported in Achilles tendinopathy (Suhubert et 
al. 2005). Despite the lack of infiltration of inflammatory cells in tendinopathic 
tissues, disturbances in inflammatory response may still be associated with the 
development of tendinopathy. Expression of cyclooxygenase-2, prostaglandin E2 and 
TGF-betal was detected in tendinopathic specimens (Fu et al. 2002b; Fredberg and 
Stengaard-Pedersen 2008). Although deposits of calcium phosphate salts such as 
hydroxyapatite and calcium pyrophosphate have been reported in spontaneously 
ruptured tendon (Jsozsa et al. 1980; Kannus and Joszsa 1991), the association of 
calcium deposits with the pathological process of tendon degeneration and rupture is 
not clear at present. 
To facilitate the study of the pathogenesis of tendinopathy, animal models are 
required. Current animal models are mainly established by overuse or injection of 
collagenase and cytokines such as PGE2 (Warden 2007). However, there has been no 
report on the animal models for the study of pathogenesis of calcific tendinopathy. 
Recent studies reported that human and mouse tendons harbored a unique cell 
population with universal stem cell characteristics (tendon stem / progenitor cells) 
and they could differentiate into chondrocytes and osteoblasts (Bi et al. 2007 
Salingacamboriboon et al. 2003; de Mos et al. 2007). These isolated tendon stem / 
progenitor cells could regenerate tendon-like tissues after extended expansion in 
vitro and transplantation in vivo (Bi et al. 2007). Chondrocyte markers were 
expressed in the clinical samples of calcific insertional Achilles tendinopathy 
(Maffulli et al. 2006) and rotator cuff tendinopathy (Sharma and MaffUlli 2005; 
Yokota et al. 2005). It implies that the chondral metaplasia in insertional 
tendinopathy and ectopic ossification in calcific tendinopathy may be due to 
erroneous differentiation of tendon cells. However, it is not known if it could be 
observed in the healing responses to degenerative tendon injuries in vivo. In this 
study, we reported spontaneous acquisition of chondrocyte phenotype and ectopic 
bone formation in a collagenase-induced tendon injury rat model. The association of 
cartilaginous metaplasia and ossification with tendon degeneration at different times 
and locations were examined. 
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Materials and Methods 
Collagenase-induced Injury 
The use of rats for experiments in this study was approved by the animal research 
ethics committee of the authors' institution. Thirty-eight male Sprague Dawley rats, 
(8 weeks, weight 200-250 grams) were used in this study. After anesthesia with 2.5% 
pentobarbital (4.5 mg/kg body weight), hairs over the lower limb were shaved. 
Patellar tendon was located by positioning the knee at 90°. Twenty microliters 
(0.015mg/|xl in 0.9% saline , i.e. 0.3mg) of bacterial collagenase I (Sigma-Aldrich, St 
Louis, MO) or saline were injected into the patellar tendon intratendinously with a 
30G needle in one limb while the contralateral limb was left untreated (Chen et al. 
2004). Free cage activity was allowed after injection. At week 2，4，8，12 and 16 for 
the collagenase-injected group and at week 16 for saline group, the rats were killed 
and the patellar tendon was harvested for routine histology, immunohistochemistry 
and von Kossa staining (n=6 for each time point). Two rats with collagenase injection 
were sacrificed at week 32 for viva-CT imaging. 
General Histology and Immunohistochemistry 
The patellar tendon was washed in PBS, fixed in buffered formalin, and then cut 
longitudinally to 5-\im thick sections and mounted on 
3-aminopropyl-triethoxy-silane (Sigma-Aldrich, St Louis, MO) coated slides. After 
deparaffination， the sections were stained with haematoxylin and eosin. 
Immunohistochemistry was done as described previously (Lui et al. 2007; Fu et al. 
2003). Briefly, after removal of paraffin and rehydration, the sections were 
decalcified with 9% formic acid for 10 minutes and wash for 1 minute. Endogenous 
peroxidase activity was quenched with 3% hydrogen peroxide for 20 minutes at 
room temperature. Antigen retrieval was then performed with 2mg/ml protease 
(Calbiochem, Bie and Bemtsen, R0dovre, Denmark) at 37C for 30 minutes for 
collagen type II detection; 2 mg/ml hyalurondiase (Sigma-Aldrich, St Louis, MO) at 
room temperature for 30 minutes, and then digest with 0.02mg/ml protease at room 
temperature for 30 minutes for collagen type X detection; 1 mg/ml hyalurondiase at 
37C for 45 minutes, followed by incubation with lOmM citrate buffer at 74C for 20 
minutes for sox 9 detection. After blocking with 5% normal goat serum, the sections 
were stained with specific antibodies against collagen type II (neomarkers-Biogen, 
Lab Vision, USA; 1:100)，collagen type X (Sigma-Aldrich, St Louis, MO; 1:100)，or SOX 9 (Santa Cruz Biotechnology, CA; 1:30) in a humid chamber at 4C ovemi^t. 
The spatial and temporal localization of these proteins were visualized by incubating 
with goat anti-mouse/rabbit IgG horseradish peroxidase (HRP)-conjugated secondary 
antibody (both from Chemicon International, Temecula, CA; cat no: AP124P and 
AP132P, respectively) for an hour, followed by 3,3' diaminobenzidine 
tetrahydrochloride (DAKO, Glostrup, Denamark) in the presence of H2O2. 
Afterwards, the sections were rinsed, counterstained in hematoxylin, dehydrated with 
graded ethanol and xylene, and mounted with p-xylene-bis-pyridinium bromide 
(DPX) permount (Sigma Aldrich, St Louis, MO). Primary antibody was replaced 
with blocking solution in the controls. For good reproducibility and comparability, all 
incubation times and conditions were strictly controlled. The sections were examined 
under light microscopy (Leica DMRXA2, Leica Microsystems Wetzlar GmbH, 
Germany). Collagen fiber alignment was examined by polarization microscopy 
(Leica DMRB, Leica Microsystems Wetzlar GmbH, Germany). 
von Kossa Staining 
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Sections were deparaffinized and rehydrated with xylene and graded ethanol. They 
were then incubated with 1% silver nitrate solution under light bulb illumination for 
1 hour, followed by incubation in 5% sodium thiosulfate solution for 5 minutes to 
remove unreacted silver. Slides were then washed and counterstained with 0.2% 
nuclear fast red solution. Finally, stained slides were dehydrated and mounted with 
DPX. The calcium nodules appeared brown. 
viva CT Scanning 
A fan-beam viva CT system (VivaCT40, Scanco Medical AG, Bassersdorf, 
Switzerland) was used to locate the mineralized tissue in the tendon mid-substance 
and to study its 3D structure. The patellar tendon was immersed in 70% ethanol and 
scanned transversely, with vertical displacement of 30|im. The sections were 
3-dimensionally reconstructed using the built-in software. 
Image analysis 
The whole histological section of tendon samples was imaged with a Leica 
DM5000B microscope and DFC 490 Digital camera (optical maginifcation: 16X) 
under standardized illumination and photographic conditions. Image analysis was 
performed with Image Pro Plus (MediaCybemetics, Bethesda, MD). Image 
segmentation was performed to include the whole tendon section by selecting the 
background and took inverse of the selection. A binary mask of the segmented image 
was created with "Dilate" and "Close" filter. The processed binary image was 
thresholded to create a region of interest (ROI) inscribing the whole tendon section 
and the total area of the tendon section was measured. The ROI was then applied to 
the original image for measurement of percentage area of specific staining. The 
immunoreactivity of Collagen Type II was thresholded with a set of standardized 
colour space parameters which selected the brown colour of immunopositive signal. 
The positive Von Kossa staining was thresholded as black colour. For the evaluation 
of the extent of degenerative injuries with polarization macroscopic imaging, the 
darkened regions in tendon samples indicated the loss of collagen birefringence in 
contrast to the brightened collagen fibres. These darkened regions were thresholded 
as dark brown and black colour with a standardized set of colour space parameters 
for all samples. Since only the polarization images, von Kossa stain and 
immunohistochemcial staining of type II collagen revealed spatial information with 
respect to the whole tendon section at a low magnification, image analyses to obtain 
percentage area of positive staining or birefringence were performed only on these 
imaged specimens. As the immunopositivity of sox 9 and type X collagen was 
observable only at higher magnification, the percentage area of positive staining for 
the whole tendon section was not measured. 
Data Analysis 
The percentage area of loss of collagen birefringence, type II and type X collagen 
signals out of the total tendon area at different times was presented in a boxplot. To 
compare the difference among different time points, Kruskal-Wallis test was used 
followed by post-hoc comparison of different time points with saline control using 




Haematoxylin and Eosin Staining 
The tendon swollen after injection with collagenase at week 2 and it reduced with 
time afterwards. The cell density increased markedly at week 2 and week 4 (Figure 
IB, C). There was loss of matrix organization. Vascularity increased at week 2 and 
reduced slightly at week 4 (Figure IB, C，arrow). Cells separated from the 
pericellular matrix by lacunar space, resembling chondroytes, were first observed at 
week 4 (Figure IC, arrowhead). The cell density and vascularity decreased at week 8 
(Figure ID), indicating that the tissue was trying to heal. However, chondrocyte-like 
cells still existed. The condition deteriorated at week 12 with increase in cell density 
and vasculature (Figure IE). Calcific deposits were present in all samples. Many 
chondrocyte-like cells were observed and some of them were embedded within the 
matrix surrounding the calcific deposits (Figure IE, arrowhead). Larger area of 
calcification and more chondrocyte-like cells were observed at week 16 (Figure IF). 
Pore structure with lining, marrow-like structures (Figure IR, star) and blood vessels 
(Figure IR, rectangle) were observed at week 12 and week. 16 inside the calcific 
deposits. Less vasculature was observed at week 16 but the cellularity remained high. 
There was absence of infiltration of inflammatory cells up to week 16. These changes 
were not observed in the saline-injection control (Figure lA). Tendon cells were 
well-aligned within the tightly packed and longitudinally arranged collagen fibrils. 
Polarization Microscopy 
Collagen fiber alignment was observed under polarization microscopy and we 
measured the percentage area of loss of collagen birefringence (Figures IG-L and 2). 
There was significant loss of collagen birefringence at all time points compared with 
saline control (p=0.012 overall, p二0.004 for post-hoc comparisons) (Figure 2). Focal 
loss of collagen birefringence occurred at week 12 (Figure IK) and week 16 (Figure 
IL). Characteristic collagen alignment as in trabecular bone was observed in the 
calcific deposits in some specimens at week 16 (Figure IL, insert). There was no 
degenerative change of the extracellular matrix in the saline-injection control as 
indicated by high collagen birefringence (Figure IG). 
von Kossa Staining 
We examined the degree of matrix mineralization with von Kossa staining. Focal 
matrix mineralization was detected in one sample at week 8 (Figure IP) and all 
samples with higher intensity at week 12 (Figure IQ) and week 16 (Figure IR). 
Interestingly, clear zone was observed in the centre of some calcific deposits at week 
12 and week 16. There was no von Kossa staining in saline-injection control (Figure 
IM). There was significant higher percentage area of von Kossa staining at week 12 
and week 16 compared to the saline control (p<0.001 overall and p=0.004 for 
post-hoc comparisons) (Figure 2). 
viva-CT 
We measured the 3-D structure of the calcific deposits in injured tendon at week 32 
by viva-CT (Figure 3A & B，arrow). The calcific deposits have porous structures 
(Figure 3C, arrowhead), and were distributed throughout the tendon. 
Expression of Type II Collagen 
We measured the expression of type II collagen by immunohistochemistry. 
Immunopositivity was first observed at week 2 mainly in tendon cells with some - ^ • 
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Staining of its surrounding extracellular matrix (Figure 4B). The staining was mainly 
localized at the chondrocytes and the extracellular matrix of tendon cells at week 4 
(Figure 4C). There was intense staining at week 8 and it occurred mainly at the 
chondrocyte-like cells and their surrounding matrix at the calcific deposits. However, 
tendon cells were not stained (Figure 4D). Similar results were observed at week 12 
(Figure 4E) and week 16 (Figure 4F). However, the central part of the calcified 
deposit was not stained at week 16 (Figure 4F, triangle). There was no expression of 
type II collagen in saline-injection control (Figure 4A). There was significant higher 
percentage area of type II collagen immunopositivity at week 12 and week 16 
compared to that in the control (p<0.001 overall, p=0.004 for post-hoc comparisons). 
Expression of Type X Collagen 
Type X collagen, a marker of hypertrophic chondrocytes and indication of 
endochondral ossification, was detected in chondrocyte-like cells at week 8 (Figure 4J)，in some calcific deposits and their surrounding chondrocyte-like cells at week 12 
(Figure 4K) and all calcific deposits and their surrounding chondrocyte-like cells at 
week 16 (Figure 4L). There was no expression of type X collagen in saline-injection 
control (Figure 4G). 
Expression of sox 9 
Strong expression of sox 9 was observed in tendon cells in high cell density region at 
week 2 (Figure 4N). At week 4 (Figure 40, arrowhead) and week 8 (Figure 4P, 
arrowhead), the staining intensity was reduced and weak signal was also observed in 
some chondrocyte-like cells. At week 12 (Figure 4Q) and week 16 (Figure 4R)， 
chondrocyte-like cells surrounding the calcific deposits were stained. The staining 
intensity was higher at week 12 compared to that at week 16. There was no 




Tendon degeneration is common in many chronic tendon pain including insertional 
tendinopathy and calcific tendinopathy. Little is known about their pathogenesis and 
consequently few effective therapies are available. Better understanding of their 
pathogenesis is essential for development of effective treatment modalities. We 
reported spontaneous acquisition of chondrocyte phenotype and ectopic bone 
formation as well as the association of different cell types with tendon degeneration 
after colagenase injection in tendon. 
Our result showed that collagenase injection exhibited many key features of 
tendinopathy including hypercellularity, loss of matrix organisation, increased 
vascularity and absence of infiltration of inflammatory cells as reported in previous 
studies (Fu et al. 2002a, b; 2007; Jarvinen et al. 1997; Khan et al. 1999; Riley 2005). 
The patellar tendon failed to heal by the end of week 32. In addition, we observed 
consistent spontaneous formation of calcific deposits in the mid-substances in all 
tendon specimens and it persisted up to week 32. Current animal models for the 
study of pathogenesis of tendinopathy were mainly established by overuse or 
injection of collagenase and cytokines such as PGE2 (Warden 2007). No ectopic 
mineralization and ossification were reported in these studies using these models. 
Our study demonstrated that acquisition of chondrocyte phenotype and ectopic bone 
formation were consistently induced in the mid-substances of patellar tendon after 
collagenase injection. As this model replicates key histopathological changes of 
calcific tendinopathy, it can be used as a model for the study of its pathogenesis at 
the patellar tendon. The use of collagenase to induce degenerative tendon injury for 
the study of calcific tendinopathy was further substantiated by reports showing that 
the increase of MMP-1 in human patellar tendinopathic specimens (Fu et al. 2002) 
and increase of MMPl in cultured tendon fibroblasts after large magnitude repeated 
stretching (Yang et al. 2005). The use of MMP inhibitors in clinical trials was also 
reported to be associated with clinical tendinopathy which rapidly resolved following 
cessation of therapy (Hutchinson et al. 1998; Jones et al. 1999; Tiemey et al. 1999). 
We observed transient tendon healing at week 8 after collagenase injection as 
indicated by the decrease in cellularity though degeneration of extracellualr matrix 
was still observed. Extracellular matrix synthesis and remodeling should take longer 
time to occur compared to changes in cellularity. However, the condition deteriorated 
afterwards and the tendon did not heal up with ectopic bone formation. This 
indicated that the tendon tissue was attempting to heal but failed in response to injury, 
consistent with the hypothesis of failed healing as the cause of tendinopathy (Mafulli 
et al. 2006; Riley 2005; Cook et al. 2002). 
We hypothesized that the degenerative changes and calcification were due to a 
cascade of cellular activities as a result of alteration of cell-matrix interaction in 
response to initial localized matrix degradation by collagenase as we observed 
transient healing at week 8 after collagenase injection. The injury induced by 
collagenase injection was probably limited in the first four weeks with activation of 
healing tendon cells for repair from week 4 to week 8. However, the tendon failed to 
heal as a result of altered cell-matrix interaction due to the initial degradation of type 
I collagen, leading to erroneous differentiation of some progenitor cells to 
chondrocytes and ossification was resulted. 
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Our results demonstrated that tendon calcification after collagenase-induced injury 
was mediated by endochondral ossification as type X collagen, a marker of 
endochondral ossification was expressed. Ectopic bone formation was further 
supported by the presence of collagen matrix characteristic of trabecular bone under 
polarization microscopy, bony structures as revealed by viva-CT imaging as well as 
the presence of bone marrow-like cells and vasculature inside the calcific deposits. 
The presence of a true bony deposit was also observed in clinical samples (Archer et 
al. 1993) and was suggested to be due to renewed blood supply to previously 
calcified tendon (Uhthoff 1975). Our results were also consistent with previous 
report which suggested that endochondral ossification as the mechanism of 
calcification in calcific Achilles and patellar tendinopathy (Fenwick et al. 2002). 
The central portion of some calcific deposits was not stained by von Kossa stain. 
This might be due to spontaneous resorption of the calcific deposits. The regression 
of calcific deposits was also reported clinically. The presence of both a formative and 
a resorptive phase of the calcific deposits were suggested (Uhthoff et al. 1976). 
Chondrocyte-like cells as indicated by cellular morphology, expression of sox 9 and 
type II collagen, were observed around the calcific deposits in collagenase-induced 
degenerative tendon injury. This was consistent with previous study reporting the 
presence of chondrocyte-like cells in the vicinity of mineralized nodules of clinical 
specimen of tendinopathy at rotator cuff tendon (Archer et al. 1993; Uhthoff et al. 
1976), supraspinatus tendon (Chard et al. 1994) and Achilles tendon (Maffulli et al. 
2006). There was increase in expression of aggrecan and biglycan mRNA in Achilles 
tendinopathy (Corps et al. 2006) as well as proteoglycans in patellar tendinopathy 
(Fu et al., 2007). Increased expression of type II collagen was also seen in human 
rotator cuff tendinopathy (Sharma and Maffulli 2000; Yokota et al. 2005). There was 
overexpression of chondrocyte markers in an overuse rat model (Archambault et al., 
2007). Not all the chondrocyte-like cells in our study expressed type II collagen and 
SOX 9. Similar result was also reported by Archer et al. (1993). 
We reported the expression of type II collagen and sox 9 by fibroblast-like cells 
which preceded the expression of these markers in chondrocyte-like cells. We 
propose that erroneous cell differentiation during healing might account for tendon 
degeneration and tendon calcification. This is corroborated with other studies which 
reported the upregulation of cartilage-associated genes and down regulation of 
tendon-associated genes in rat supraspinuous tendon (Archambault et al. 2006) and 
in horse superficial digital flexor tendon (Clegg et al. 2007) after overuse injury. 
Differentiation of tendocytes into fibrocartilage has been suggested to be the 
necessary initial stage for mineralization (Uhthoff et al. 1976). Other studies also 
reported the presence of resident progenitor cells with multi-differentiation potential 
in tendon (Salingacamboriboon et al. 2003; de Mos et al. 2007; Bi et al. 2007). 
Injection of recombinant human bone morphogenetic protein -2 (rhBMP-2) into 
tendon increased ectopic bone formation, indicating that tendon consisted of cells 
that were responsive to BMP and were capable of differentiating along the 
chondro-osseous pathway (Hashimoto et al. 2007). The differentiation of tendon 
progenitor cells into chondrocytes and bone cells was reported to be modulated by 
the expression of small leucine-rich repeat proteoglycans such as biglycan and 
fibromodulin, which control the differentiation process associated with BMP-2 
activities (Bi et al. 2007). Clinically, there was ectopic overexpression of BMPs in 
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the subacromial bursa and it was suggested to account for the chondrogenic 
transformation and ectopic mineralization of rotator cuff tendon in patients 
(Neuwirth et al. 2006). Msx2 was reported as a repressor of osteoblastic 
differentiation and BMP-2 is a well known activator that can repress the effect of 
Msx2 (Yoshizawa et al. 2004). We speculate that over-expression or increased 
activity of BMP-2 due to altered matrix-cell interaction leads to the decrease in Msx2 
expression in degenerative tendon which further leads to erroneous osteoblastic 
differentiation of tendon progenitors and calcification. This will be investigated in 
future studies. 
While our and other studies have observed the presence of chondrocyte phenotypes 
adjacent to the calcific deposits, ectopic chondrogenesis is possibly not by itself the 
cause of tendon calcification. Additional local factors such as shear and compressive 
forces (Almekinders et al. 2002; Hamilton and Purdam, 2004) or tissue hypoxia 
(Archambault et al. 1995; Bestwick and Maffulli 2004) are required to cause local 
cell and matrix changes which can then initiate crystal deposition. 
In conclusion, spontaneous cartilaginous metaplasia and ossification were observed 
in a collagenase-induced degenerative tendon injury model. As this model replicates 
key histopathological changes of calcific tendinopathy, it constitutes a valuable 
model for unraveling the common molecular pathways of its pathogenesis at the 
patellar tendon. The temporal and spatial relationship of degenerative injuries, 
chondrogenesis and tissue ossification suggest a sequence of events that involves 
aberrant cell differentiation in damaged extracellular matrix which favors ectopic 
ossification. 
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Figure 1. Histological, polarization and von Kossa staining of patella tendon at 
different times after inttratendinous collagenase injection. 
(A-F) Haematoxylin and Esoin Staining. After intratendinous collagenase injection, 
the cell density and vascularity increased with time, with transient decrease at week 8. 
Chondrocyte-like cells first appeared at week 4 and they surrounded calcific deposits 
starting from week 8. There was no sign of infiltration of inflammatory cells. These 











changes were not observed in saline-injection control. Bar = lOOjim 
(G-L) Polarization Microscopy. There was progressive loss of collagen birefringence 
with time. Focal loss of collagen birefringence occurred at week 12 and week 16. 
Trabecular-like collagen fiber alignment was observed in the calcific deposits in 
some specimens at week 16 (insert). The extracellular matrix of the saline-injection 
control remained intact. Bar = lOOOjim; Bar = lOOjim (insert) 
(M-R) von Kossa Staining. Mineralized matrix was observed starting from week 8. 
There was no staining in saline-injection control. Note the presence of marrow-like 
structures (star) and blood vessels (rectangle) within the calcific deposit at week 16. 
Bar: same as A-F 
Saline control at week 16: A, G, M; week 2: B, H，N; week 4: C, I，O; week 8: D，J, P; 
week 12: E，K, Q; week 16: F, L, R. 
Arrow: blood vessels; arrowhead: chondrocyte-like cells; star: marrow-like cells 
inside calcific deposit; rectangle: blood vessels inside calcific deposit 
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Figure 2. Graph showing percentage area of loss of collagen birefringence, type II 
collagen immunopositive stain and von Kossa stain at different times after 
intratendinous collagenase injection. 
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Figure 3. viva-CT imaging of calcific deposits inside tendon at week 32 after 
collagenase injection. Note the localization of calcific deposits (arrow) in the tendon. 
Note the porous structures of the calcific deposits (arrowhead) (A) Anterior-posterior 
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Figure 4. Immunohistochemistry of patella tendon at different times after 
inttratendinous collagenase injection. 
(A-F) Immunohistochemistry of Type II Collagen. Immunopositivity was first 
observed at week 2 in tendon cells. There was intense staining of the 




week 8, week 12 and week 16. The central part of the calcific deposit was not stained 
in some specimens (triangle). There was no expression of type II collagen in 
saline-injection control. 
(G-L) Immunohistochemsitry of Type X Collagen. Immunopositivity was observed 
in the calcific deposits and their surrounding chondrocyte-like cells. There was no 
expression of type X collagen in saline-injection control. 
(M-R) Immunohistochemistry of sox 9. There was strong expression of sox 9 in 
fibroblast-like cells at week 2. At week 4 and week 8, weak signal was observed in 
some chondrocyte-like cells. At week 12 and week 16，chondrocyte-like cells 
surrounding calcific deposits were stained. There was no expression of sox 9 in 
saline-injection control. 
Saline control at week 16: A, Q M; week 2: B, H, N; week 4: C, I，O; week 8: D，J, P; 
week 12: E，K, Q; week 16: F，L，R. 
Arrowhead: chondrocyte-like cells; triangle: clear zone of calcific deposit; CR: 
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EXPRESSION OF TYPE II COLLAGEN AND TISSUE CALCIFICATION IN COLLAGENASE-INDUCED 
TENDON DEGENERATION 
Fu SC, Chan LS, Chan, KM, Hung LK, Lui PY 
].Department of Orthopaedics and Traumatology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China 
2, The Hong Kong Jockey Club Sports Medicine and Health Sciences Centre, Faculty ofMcdicinc, 
The Chinese University of Hong Kong, Hong Kong SAR, China 
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INTRODUCTION 
Tendon degeneration is involved in various kinds of chronic tendon pain such as insertion tendinopathy, 
calcified tendinopathy. Failed cell differentiation into tenocytes was implicated with the detection of chondrocyte 
markers in clinical samples of Achilles tendinopathy (1). It was speculated that a process similar to endochondral 
ossification may account for the calcification in calcified tendinopathy (2). However, il is not known if tendon 
healing to degenerative injuries would lead to erroneous differentiation into chondrocyte and even ectopic bone 
formation. In the present study, we used a rat model of collagenase-induced tendon degeneration to study if 
acquisition of chondrocyte phenotype and tissue calcification were associated with the failed healing to tendon 
degeneration. 
METHODOLOGY 
A total of 36 male Sprague Dawley rats (6-8 weeks old) were used in ihe present study. A 20 [il aliquot of 
0.0)5 mg/ul collagenasc was injected intratendinously into the left patellar tendon of 30 rats. Equal volume of 
saline was injected in the remaining 6 rats as control. The rats receiving collagenase injection were euthanized at 
2, 4, 8, 12 and 16 weeks post injection (n=6), and the saline control were euthanized al 16 weeks post-injection. 
Patellar tendon samples were harvested, fomialin-fixed and paraffin-embedded for preparations of 5 um Ihick 
sections. Hematoxylin and Eosin staining was performed and the extent of degenerative injuries was evaluated 
by polarization microscopy as loss of collagen birefringence. Expression of Type II collagen, sox 9, osteocalcin 
and MMP13 was determined by Iinmunohistochemisti-y. Tissue calcification was detected by von Kossa staining. 
RESULT 
The results showed thai collagenase-induced degenerative tendon injuries were not healed up to 16 
weeks post injury, with persistent loss of collagen birefringence and progressive tissue calcification. Expression 
of "Type II collagen became evident al 4 weeks post injury, while tissue calcification was obvious from 12 weeks 
post injury (Figure 1). Expression of Type II collagen was localized in the regions of disturbed matrix (loss of 
birefringence) in 4 weeks post injury and it was mainly detected around the sites of calcification from 8 to 16 
weeks post injury (Figure 2). Von Kossa staining revealed focal sites of intratendinous calcification and 
chondrocyte-like cells were observed at the edges of the calcification sites (Figure 3). Inimunoreactivity of sox 9 
only found in chondrocyte-like cells in the degenerative tendons. All tendon samples were negative for 
immunostaining of MMP13 and osteocalcin. 
Figure 1 
Figure 2 
國 loss of collagen birefringence 
國 ImmunorAactlvltv of Col II 
[ 0 Von Kossa stain 
Figure 3 
_ _ _ I 
DISCUSSION 
We observed failed healing of degenerative tendon injuries, which was associated with the acquisition of 
chondrocyte phenotype and tissue calcification in tendons. It is possible that degenerative injuries could not be 
healed .properly and erroneous cell differentiation was resulted. The temporal and spatial relationship of 
degenerative injuries, chondrogenesis and tissue calcification may suggest a sequence of events that involve 
altered cellular responses in damaged extracellular matrix which favour ectopic calcification. However, the lack 
of MMP13 and osteocalcin expression did not support the occurrence of endochondral ossification, suggesting 
that failed healing to tendon degeneration can nol fully explain the clinical observation of calcified tendinopathy. 
References: 
1. Corps AN et al. Rheumatology. 45(3):291-4,2006. 
2. Fenwick S et al. Rheumatology. 41(4):474-6, 2002. 
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SUBSTANCE P EXPRESSION WAS ASSOCIATED WITH TENDON PAIN IN A RAT MODEL OF 
COLLAGENASE-INDUCED TENDON INJURIES 
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INTRODUCTION: 
Chronic tendinopathy is characterized with longstanding tendon pain, but the origins of pain remains 
unclear. As increased substance P (SP) positive nerve fibres were found in tendon sample from chronic 
tendinopathy (1)，it is possible that SP in tendon degeneration contributed to increased nociception. In previous 
experimental studies, collagenase-induccd degenerative tendon injuries showed similar histopathological 
features of tendinopathy, but it is not known if increased nociception was associated with these histopathological 
features. Sincc knee pain in rats could be measured as increased double stance duration (2), wc propose to 
characterize nociceptive responses by gait analysis in a rat model of collagenasc-induccd injuries, and determine 
if SP expression in the degenerative tendons was associated with increased nociception. 
METHODS： 
A total of 36 male Sprague Dawley rats (6-8 weeks old) were used in the present study. A 2 0 |xl aliquot of 
0.015 mg/ul collagenase was injected intratendinously into the left patellar tendon of 30 rats. Equal volume of 
saline was injected in the remaining 6 rats as control. Video capturing for gait analysis was performed in the 
control group as well as the collagenase injection groups at 2 weeks, 4 weeks, 8 weeks, 12 weeks and 16 weeks 
post injury (n= 6). During video capturing, the rats were forced to nm on a transparent track. Black ink joint 
markers were labeled on shaven skin of the hind limbs at the major joints. A high-speed video camera (JVC 9600, 
Japan) was used (o record the movement of hind limbs at 100 Hz. The video data were captured and analyzed by 
a motion analysis system (Ariel Performance Analysis System, USA). Trials with propagation speeds not less 
than 0.02m/s were obtained to measure the double stance duration. After video capturing, the rats were 
eunthanized and the left patellar tendons were harvested for histological processing and SP 
immunohistochcmistry. 
RESULTS: 
As compare to the saline control, the double stancc duration of the rat gait was increased (p=0.048, 
One-way ANOVA), indicating knee pain according to the study by Coulthard(2). However, the double stance 
duration restored to normal level at 8 weeks and increased again at 16 weeks post injury (Fig IB). A similar 
biphasic pattern was noticed in the change of immunopositivily of SP (p<0.005, Kruskal-Wallis Test) in the 
injured tendons (Fig lA). Correlation analysis by Spearman's rho test revealed significant association between 
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Figure 1 A&B. (A) The double stance duration (p=0.048, One-way ANOVA), and (B) the immunoreactvity of SP 
on the tendon section (p<0.005, Kruskal-Wallis Test) at different time point. 
DISCUSSIONS: 
This was the first attempt to measure tendon pain in a collagenasc-induccd degenerative tendon injury 
model which mimickcd the histopatliology of chronic tendinopathy. The painfiil response was monitored by 
increased double stance duration which may reduce nociceptive stimuli associated with loading of hindlimbs. Wc 
found that the degenerative injuries were not healed up to 16 weeks post injury, and increased double stance 
duration indicated persistent knee pain. It indicated that die rat model of collagcnase-induced injury exhibited 
crucial characteristics of chronic tendinopathy, namely pain and failed healing. Since the expression of SP in the 
iiyured tendons was correlated to the pain level, it is possible that SP may play a role in development of chronic 






i lie  e en though SP is a well-known 
ncccssary for the exploration of the roles of SP in chronic 
Schubert TE et al. Ann Rheum Di$. 64(7):1083-6.2005 
Coulthaid Petal .J Neurotci Methods. 116(2): 197-213. 
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